[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 469
1. Pejcić I, Vrbić S, Filipović S, Sćekić M, Petković I, Pejcić L, Djenić N: [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site]. Vojnosanit Pregl; 2010 Sep;67(9):723-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Following the routine light microscopy, all histological findings were classified into one of the following three groups: plano-cellular carcinoma--8 patients; adenocarcinoma--33 patients; unclassifiable (undifferentiated) carcinoma--22 patients.
  • In all the cases we evaluated 8 serum tumor markers: alpha-fetoproteins (AFP), chronic gonadotrophin beta submit, human (beta-HCG), neuron specific enolase (NSE), marker of malignant ovarian tumors (CA 125), prostate-specific antigene (PSA), marker of malignant brest tumor (CA 15-3), marker of malignant pancreas tumor and gastrointestinal tumor (Ca 19-9), carcinoembryonic antigen (CEA) at the time of diagnosis.
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged


2. Deenadayalan A, Heaslip D, Rajendiran AA, Velayudham BV, Frederick S, Yang HL, Dobos K, Belisle JT, Raja A: Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients. Mol Cell Proteomics; 2010 Mar;9(3):538-49
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Identification of Mycobacterium tuberculosis antigens inducing cellular immune responses is required to improve the diagnosis of and vaccine development against tuberculosis.

  • Genetic Alliance. consumer health - Tuberculosis.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 1998 Jun 11;393(6685):537-44 [9634230.001]
  • [Cites] Eur J Immunol. 1998 Dec;28(12):3949-58 [9862331.001]
  • [Cites] Infect Dis Clin North Am. 1999 Mar;13(1):169-85, vii-viii [10198798.001]
  • [Cites] Mol Microbiol. 1999 Sep;33(6):1103-17 [10510226.001]
  • [Cites] Vaccine. 2004 Dec 21;23(6):780-8 [15542202.001]
  • [Cites] J Clin Microbiol. 2005 Jan;43(1):57-65 [15634951.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):467-72 [15626759.001]
  • [Cites] Clin Diagn Lab Immunol. 2005 Feb;12(2):354-8 [15699433.001]
  • [Cites] Int J Tuberc Lung Dis. 2005 Feb;9(2):195-9 [15732740.001]
  • [Cites] Nat Med. 2005 Apr;11(4 Suppl):S33-44 [15812488.001]
  • [Cites] Infect Immun. 2005 Jun;73(6):3547-58 [15908384.001]
  • [Cites] Microbes Infect. 2005 Apr;7(4):776-88 [15823514.001]
  • [Cites] J Clin Microbiol. 2005 Jul;43(7):3185-91 [16000433.001]
  • [Cites] Microbiology. 2005 Jul;151(Pt 7):2411-9 [16000731.001]
  • [Cites] FEMS Microbiol Lett. 2005 Aug 1;249(1):87-94 [16006064.001]
  • [Cites] Infect Immun. 2005 Aug;73(8):4676-83 [16040980.001]
  • [Cites] Nat Rev Immunol. 2005 Aug;5(8):661-7 [16056257.001]
  • [Cites] Antimicrob Agents Chemother. 2005 Sep;49(9):3707-14 [16127044.001]
  • [Cites] Infect Immun. 1999 Nov;67(11):5967-71 [10531255.001]
  • [Cites] Scand J Immunol. 2000 Jan;51(1):79-86 [10632980.001]
  • [Cites] J Clin Microbiol. 2000 Sep;38(9):3285-90 [10970372.001]
  • [Cites] Electrophoresis. 2000 Nov;21(17):3740-56 [11271494.001]
  • [Cites] Infect Immun. 2001 Aug;69(8):4839-45 [11447158.001]
  • [Cites] Proteomics. 2001 Apr;1(4):574-86 [11681210.001]
  • [Cites] J Clin Microbiol. 2002 Feb;40(2):704-6 [11826002.001]
  • [Cites] J Bacteriol. 2002 Jul;184(13):3485-91 [12057942.001]
  • [Cites] Anal Chem. 2002 Oct 15;74(20):5383-92 [12403597.001]
  • [Cites] Infect Immun. 2003 Jan;71(1):483-93 [12496199.001]
  • [Cites] Infect Immun. 2003 Feb;71(2):708-16 [12540549.001]
  • [Cites] Infect Immun. 2003 Apr;71(4):1929-37 [12654810.001]
  • [Cites] Infect Immun. 2003 Jul;71(7):3927-36 [12819079.001]
  • [Cites] Antimicrob Agents Chemother. 2003 Sep;47(9):2903-13 [12936993.001]
  • [Cites] Anal Chem. 2003 Sep 1;75(17):4646-58 [14632076.001]
  • [Cites] Mol Cell Proteomics. 2003 Dec;2(12):1284-96 [14532352.001]
  • [Cites] Infect Immun. 2004 Jan;72(1):381-8 [14688119.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):314-9 [14695899.001]
  • [Cites] Scand J Immunol. 2004 Jan;59(1):16-24 [14723617.001]
  • [Cites] Mol Cell Proteomics. 2004 Jan;3(1):24-42 [14557599.001]
  • [Cites] Int J Med Microbiol. 2003 Dec;293(6):391-401 [14760970.001]
  • [Cites] FEMS Microbiol Lett. 2004 Mar 12;232(1):51-9 [15019734.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12652-7 [15314217.001]
  • [Cites] Infect Immun. 2004 Nov;72(11):6471-9 [15501778.001]
  • [Cites] Nature. 1970 Aug 15;227(5259):680-5 [5432063.001]
  • [Cites] J Immunol Methods. 1987 Apr 2;98(1):5-10 [3104476.001]
  • [Cites] Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S353-9 [2652252.001]
  • [Cites] Infect Immun. 1991 Jan;59(1):372-82 [1898899.001]
  • [Cites] Infect Immun. 1991 Feb;59(2):665-70 [1898911.001]
  • [Cites] Anal Biochem. 1992 May 15;203(1):173-9 [1524213.001]
  • [Cites] J Immunol Methods. 1993 May 5;161(1):29-39 [8486927.001]
  • [Cites] J Exp Med. 1993 Dec 1;178(6):2249-54 [7504064.001]
  • [Cites] Infect Immun. 1995 Mar;63(3):954-60 [7868268.001]
  • [Cites] Infect Immun. 1995 Apr;63(4):1491-7 [7890415.001]
  • [Cites] Anal Biochem. 1995 Jan 1;224(1):451-5 [7710111.001]
  • [Cites] Vet Immunol Immunopathol. 1995 Sep;48(1-2):183-90 [8533313.001]
  • [Cites] Anal Chem. 1996 Mar 1;68(5):850-8 [8779443.001]
  • [Cites] Infect Immun. 1996 Nov;64(11):4834-7 [8890247.001]
  • [Cites] N Engl J Med. 1996 Dec 26;335(26):1956-61 [8960475.001]
  • [Cites] Infect Immun. 1998 Jan;66(1):176-80 [9423855.001]
  • [Cites] Lancet. 2005 Oct 22-28;366(9495):1414-6 [16243075.001]
  • [Cites] Vaccine. 2005 Dec 1;23(48-49):5655-65 [16157425.001]
  • [Cites] Tuberculosis (Edinb). 2005 Sep-Nov;85(5-6):385-94 [16253564.001]
  • [Cites] J Bacteriol. 2006 Feb;188(4):1364-72 [16452418.001]
  • [Cites] Mol Microbiol. 2006 May;60(4):999-1013 [16677310.001]
  • [Cites] J Immunol. 2006 Jul 1;177(1):422-9 [16785538.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11346-51 [16844784.001]
  • [Cites] Nat Rev Immunol. 2006 Sep;6(9):699-704 [16917508.001]
  • [Cites] Microbiol Mol Biol Rev. 2006 Sep;70(3):755-88 [16959968.001]
  • [Cites] Science. 2006 Oct 20;314(5798):454-8 [17053144.001]
  • [Cites] Lancet. 2006 Dec 16;368(9553):2142-54 [17174706.001]
  • [Cites] Infect Immun. 2007 Jan;75(1):527-30 [17088357.001]
  • [Cites] Mem Inst Oswaldo Cruz. 2006 Dec;101(8):857-61 [17293979.001]
  • [Cites] Proteomics. 2007 May;7(10):1702-18 [17443846.001]
  • [Cites] Infect Immun. 2007 Jun;75(6):2914-21 [17387166.001]
  • [Cites] Chest. 2007 Jun;131(6):1898-906 [17565023.001]
  • [Cites] Swiss Med Wkly. 2007 Jun 30;137(25-26):357-62 [17629798.001]
  • [Cites] J Cell Sci. 2007 Aug 15;120(Pt 16):2796-806 [17652161.001]
  • [Cites] Proteomics. 2007 Sep;7(18):3332-41 [17849409.001]
  • [Cites] PLoS One. 2008;3(1):e1403 [18167562.001]
  • [Cites] Scand J Immunol. 2008 Mar;67(3):245-52 [18208443.001]
  • [Cites] Genome Biol. 2007;8(12):R265 [18078514.001]
  • [Cites] PLoS One. 2008;3(4):e1973 [18398483.001]
  • [Cites] Int J Tuberc Lung Dis. 2008 Nov;12(11):1226-34 [18926032.001]
  • (PMID = 20031926.001).
  • [ISSN] 1535-9484
  • [Journal-full-title] Molecular & cellular proteomics : MCP
  • [ISO-abbreviation] Mol. Cell Proteomics
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / HHSN266200400091C; United States / PHS HHS / / HHSN266200400091C
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Bacterial; 0 / Tumor Necrosis Factor-alpha; 207137-56-2 / Interleukin-4; 82115-62-6 / Interferon-gamma
  • [Other-IDs] NLM/ PMC2849706
  •  go-up   go-down


3. Liuba I, Walfridsson H: Focal atrial tachycardia: increased electrogram fractionation in the vicinity of the earliest activation site. Europace; 2008 Oct;10(10):1195-204
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Body Surface Potential Mapping / methods. Diagnosis, Computer-Assisted / methods. Heart Conduction System / physiopathology. Tachycardia, Ectopic Atrial / diagnosis. Tachycardia, Ectopic Atrial / physiopathology
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18662940.001).
  • [ISSN] 1532-2092
  • [Journal-full-title] Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • [ISO-abbreviation] Europace
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


Advertisement
4. Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, Lesavre P, Noël LH: ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant; 2005 Jul;20(7):1392-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Renal histology revealed a high percentage of active glomerular lesions (50%), mainly cellular crescents, 28% of them with glomerular necrosis.
  • Chronic tissue damage with glomerulosclerosis (21%) and diffuse interstitial fibrosis (40%) was already present at diagnosis, more prominent than in historical PR3-positive patients.
  • Renal outcome was correlated to DEI (P = 0.032) and serum creatinine at diagnosis (P = 0.04).
  • The mortality rate was high (35%) and closely related to age above 65 years at diagnosis (P = 0.014).
  • Our data underline the importance of the exact diagnosis in an active vasculitic disease process even in the absence of ANCAs.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antibodies, Antineutrophil Cytoplasmic / blood. Cohort Studies. Creatinine / blood. Female. Humans. Male. Middle Aged. Outcome Assessment (Health Care). Prognosis. Retrospective Studies. Severity of Illness Index

  • Genetic Alliance. consumer health - Vasculitis.
  • MedlinePlus Health Information. consumer health - Vasculitis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15855209.001).
  • [ISSN] 0931-0509
  • [Journal-full-title] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • [ISO-abbreviation] Nephrol. Dial. Transplant.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Antineutrophil Cytoplasmic; AYI8EX34EU / Creatinine
  •  go-up   go-down


5. Lai ML, Faa G, Serra S, Senes G, Daniele GM, Boi F, Mariotti S, Beauchemin M, Asa SL: Rhabdoid tumor of the thyroid gland: a variant of anaplastic carcinoma. Arch Pathol Lab Med; 2005 Mar;129(3):e55-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 67-year-old woman had a nodular goiter for all of her adult life and presented with a rapidly growing mass in the right lobe.
  • Histologic examination showed a highly cellular neoplasm with a solid infiltrative growth pattern.
  • [MeSH-major] Carcinoma / diagnosis. Rhabdoid Tumor / diagnosis. Thyroid Neoplasms / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans

  • Genetic Alliance. consumer health - Rhabdoid tumor.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15737050.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


6. Goh BK, Chow PK, Kesavan S, Yap WM, Ong HS, Song IC, Eu KW, Wong WK: Intraabdominal schwannomas: a single institution experience. J Gastrointest Surg; 2008 Apr;12(4):756-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multiple preoperative investigations including endoscopies with biopsies and computed tomography (CT) scans were performed, but none yielded a correct definitive preoperative diagnosis.
  • Pathological examination demonstrated the 11 gastrointestinal tract (GIT) schwannomas to be solid homogenous tumors, which were highly cellular and were composed of spindle cells with positive staining for S100 protein.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Gastrointestinal Neoplasms / diagnosis. Gastrointestinal Neoplasms / pathology. Gastrointestinal Neoplasms / surgery. Humans. Male. Middle Aged. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1995 Feb;19(2):207-16 [7530409.001]
  • [Cites] Am J Surg Pathol. 2001 Jul;25(7):846-55 [11420455.001]
  • [Cites] Ann Acad Med Singapore. 2006 Jan;35(1):45-8 [16470274.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1975 Oct;125(2):391-4 [1200238.001]
  • [Cites] Clin Radiol. 1996 Jul;51(7):517-8 [8689831.001]
  • [Cites] Hum Pathol. 1988 Mar;19(3):257-64 [3126126.001]
  • [Cites] Am Surg. 1993 May;59(5):293-6 [8489097.001]
  • [Cites] Hum Pathol. 2002 May;33(5):459-65 [12094370.001]
  • [Cites] Radiology. 2003 Feb;226(2):527-32 [12563150.001]
  • [Cites] AJR Am J Roentgenol. 2005 Mar;184(3):797-802 [15728600.001]
  • [Cites] Curr Opin Gastroenterol. 2007 Sep;23(5):539-43 [17762560.001]
  • [Cites] Am J Surg Pathol. 1999 Apr;23(4):431-6 [10199472.001]
  • [Cites] Hepatogastroenterology. 1998 Sep-Oct;45(23):1764-6 [9840143.001]
  • [Cites] Langenbecks Arch Surg. 2006 Aug;391(4):322-9 [16402273.001]
  • [Cites] Histopathology. 2006 Apr;48(5):536-45 [16623779.001]
  • [Cites] Aust N Z J Surg. 1995 Mar;65(3):197-200 [7887865.001]
  • [Cites] Br J Radiol. 1997 Sep;70(837):952-5 [9486074.001]
  • [Cites] World J Gastroenterol. 2007 Feb 28;13(8):1275-8 [17451214.001]
  • [Cites] Pathol Res Pract. 2002;198(9):605-13 [12440783.001]
  • [Cites] Histopathology. 1995 Oct;27(4):355-60 [8847066.001]
  • [Cites] Radiographics. 2003 Mar-Apr;23 (2):283-304, 456; quiz 532 [12640147.001]
  • [Cites] Hum Pathol. 1997 Mar;28(3):304-8 [9042794.001]
  • [Cites] Am J Surg. 2006 Jul;192(1):14-8 [16769268.001]
  • [Cites] J Ultrasound Med. 2004 Nov;23 (11):1527-30 [15498921.001]
  • [Cites] Dig Surg. 2006;23(4):265-9 [17035701.001]
  • (PMID = 18074186.001).
  • [ISSN] 1091-255X
  • [Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
  • [ISO-abbreviation] J. Gastrointest. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Kollur SM, El Hag IA: FNA of breast fibroadenoma: observer variability and review of cytomorphology with cytohistological correlation. Cytopathology; 2006 Oct;17(5):239-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Causes of diagnostic errors included marked dissociation, pleomorphism, poorly cellular smears from hyalinized fibrodenoma, lacational changes and apocrine metaplasia with cystic changes.
  • CONCLUSION: FNA was a highly sensitive method for the diagnosis of fibroadenoma.
  • [MeSH-major] Biopsy, Fine-Needle. Breast Neoplasms / diagnosis. Fibroadenoma / diagnosis
  • [MeSH-minor] Adolescent. Adult. Diagnosis, Differential. Female. Humans. Hyperplasia / pathology. Middle Aged. Observer Variation. Reproducibility of Results. Retrospective Studies. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16961651.001).
  • [ISSN] 0956-5507
  • [Journal-full-title] Cytopathology : official journal of the British Society for Clinical Cytology
  • [ISO-abbreviation] Cytopathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


8. Premasathian N, Vongwiwatana A, Taweemonkongsap T, Amornvesukit T, Limsrichamrern S, Jitpraphai S, Kositamongkol P, Mahawithitwong P, Sritippayawan S, Chanchairujira T, Nualyong C, Vareesangthip K, Vasuvattakul S, Sirivatanauksorn Y: The 37-year kidney transplantation experience at Siriraj Hospital. Clin Transpl; 2010;:141-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Delayed graft function (DGF) was found in 54% of deceased donor kidney transplantation and resulted in significantly higher rate of 1 year biopsy-proven acute rejection, longer duration of kidney transplant admission, higher admission cost and lower patient survival compared to those with immediate graft function.
  • There was no statistically significant difference in the biopsy-proven acute rejection (BPAR) free survival between deceased and living donor transplantation.
  • Proportion of cases with the diagnosis of acute rejection according to Banff 2007 classification is as follows: 32.4% acute cellular rejection (ACR), 39.4% antibody-mediated rejection (AMR) and 21.1% mixed cellular and antibody-mediated rejection.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Delayed Graft Function / etiology. Delayed Graft Function / prevention & control. Female. Graft Rejection / immunology. Graft Rejection / prevention & control. Graft Survival. Histocompatibility Testing. Humans. Immunosuppressive Agents / therapeutic use. Infant. Infant, Newborn. Laparoscopy. Living Donors / supply & distribution. Male. Middle Aged. Nephrectomy. Thailand / epidemiology. Time Factors. Treatment Outcome. Waiting Lists. Young Adult


9. Chandak GR, Janipalli CS, Bhaskar S, Kulkarni SR, Mohankrishna P, Hattersley AT, Frayling TM, Yajnik CS: Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia; 2007 Jan;50(1):63-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We found no association of the TCF7L2 genotypes with age at diagnosis, BMI or WHR, but the risk genotype at rs12255372 was associated with higher fasting plasma glucose (p = 0.001), higher 2-h plasma glucose (p = 0.0002) and higher homeostasis model assessment of insulin resistance (HOMA-R; p = 0.012) in non-diabetic subjects.
  • [MeSH-minor] Adult. Alleles. Case-Control Studies. Female. Genotype. Humans. India. Linkage Disequilibrium / genetics. Male. Middle Aged. Odds Ratio. Risk Factors. Transcription Factor 7-Like 2 Protein

  • Genetic Alliance. consumer health - Diabetes.
  • Genetic Alliance. consumer health - Diabetes, Type 2.
  • Genetic Alliance. consumer health - Diabetes mellitus type 2.
  • MedlinePlus Health Information. consumer health - Diabetes Type 2.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Diabetologia. 2007 Jan;50(1):1-4 [17096114.001]
  • [Cites] Diabet Med. 2005 Nov;22(11):1516-21 [16241916.001]
  • [Cites] Nat Genet. 2006 Mar;38(3):320-3 [16415884.001]
  • [Cites] Am J Obstet Gynecol. 2000 Feb;182(2):443-8 [10694350.001]
  • [Cites] Diabetes. 2003 Feb;52(2):568-72 [12540637.001]
  • [Cites] Diabetes. 2006 Sep;55(9):2640-4 [16936215.001]
  • [Cites] Diabetologia. 2001 Sep;44(9):1094-101 [11596662.001]
  • [Cites] Diabetes Care. 2006 May;29(5):1046-51 [16644635.001]
  • [Cites] Diabetologia. 1992 Aug;35(8):785-91 [1511807.001]
  • [Cites] J Med Genet. 2002 May;39(5):347-51 [12011155.001]
  • [Cites] Nat Genet. 2000 Sep;26(1):76-80 [10973253.001]
  • [Cites] Am J Hum Genet. 2002 Feb;70(2):425-34 [11791212.001]
  • [Cites] Diabet Med. 1991 Oct;8(8):712-7 [1838061.001]
  • [Cites] Diabetes Res Clin Pract. 1997 May;36(2):121-5 [9229196.001]
  • (PMID = 17093941.001).
  • [ISSN] 0012-186X
  • [Journal-full-title] Diabetologia
  • [ISO-abbreviation] Diabetologia
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / G0500070; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / TCF Transcription Factors; 0 / TCF7L2 protein, human; 0 / Transcription Factor 7-Like 2 Protein
  •  go-up   go-down


10. Santoro C, Rago A, Biondo F, Conti L, Pulcinelli F, Laurenti L, Perrone MP, Baldacci E, Leporace A, Mazzucconi MG: Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients. Haemophilia; 2010 Sep 1;16(5):805-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • From 1975 until December 2005, we have followed 17 GT patients: 14 type 1, 3 variant type; nine females, eight males; median age at diagnosis 9.8 years (range 1-44.5); median age at the time of the study 35.5 years (range 23.6-68.5).
  • [MeSH-minor] Adult. Aged. Delivery, Obstetric. Enzyme-Linked Immunosorbent Assay. Female. Genotype. Humans. Integrin alpha2 / genetics. Integrin beta3 / genetics. Male. Middle Aged. Mutation / genetics. Phenotype. Pregnancy. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • SciCrunch. Clinical Genomic Database: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20345392.001).
  • [ISSN] 1365-2516
  • [Journal-full-title] Haemophilia : the official journal of the World Federation of Hemophilia
  • [ISO-abbreviation] Haemophilia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / HLA Antigens; 0 / ITGA2B protein, human; 0 / ITGB3 protein, human; 0 / Integrin alpha2; 0 / Integrin beta3; 0 / Isoantibodies; 0 / Platelet Glycoprotein GPIIb-IIIa Complex
  •  go-up   go-down


11. McCaffrey JC: Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology. Laryngoscope; 2006 Jan;116(1):1-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
  • 1) To describe the clinical entity invasive well-differentiated thyroid carcinoma (IWDTC), 2) to determine prognostic factors for survival in patients with IWDTC, 3) to describe and compare types of surgical resection to determine treatment efficacy, 4) to offer a staging system and surgical algorithm for management of patients with IWDTC, 5) to examine alterations in expression of E-cadherin and beta-catenin adhesion molecules in three groups of thyroid tissue and propose a cellular mechanism for invasion of the aerodigestive tract.
  • [MeSH-minor] Adult. Aged. Analysis of Variance. Biomarkers, Tumor / blood. Biopsy, Needle. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Probability. Prognosis. Proportional Hazards Models. Retrospective Studies. Risk Assessment. Survival Analysis. Thyroidectomy / methods. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16481800.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cadherins
  •  go-up   go-down


12. Neff GW, Shire N, Ruiz P, O'Brien C, Garcia M, Dela Garza J, Rudich SR, Reddy KR: The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection. Transplant Proc; 2005 Dec;37(10):4397-402
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A retrospective analysis from June 1996 to May 2003 was performed on adult liver transplant (OLT) recipients with hepatitis C virus.
  • (1) patients with parameters suggestive of cholestatic HCV; and (2) patients with parameters consistent with acute cellular rejection.
  • Clinical parameters correlated well with diagnosis of cholestasis (r = 0.85, P < .001) whereas histological evaluation did not (r = 0.11, P = .53).
  • CONCLUSION: Clinical diagnosis parameters for RHCV with cholestasis appear more accurate than histology parameters and should be the primary consideration in directing therapy.
  • Despite timely diagnosis, cholestatic RHCV LTx recipients have a poor prognosis.
  • [MeSH-major] Cholestasis / diagnosis. Graft Rejection / etiology. Hepatitis C / diagnosis. Liver Transplantation / immunology
  • [MeSH-minor] Adult. Antiviral Agents / therapeutic use. Demography. Humans. Immunosuppression / adverse effects. Immunosuppression / methods. Immunosuppressive Agents / adverse effects. Immunosuppressive Agents / therapeutic use. Retrospective Studies. Survival Analysis. Treatment Outcome


13. Sung MT, Maclennan GT, Lopez-Beltran A, Zhang S, Montironi R, Cheng L: Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases. Am J Surg Pathol; 2008 Jan;32(1):146-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Accurate diagnosis of mediastinal seminoma is critical because of its favorable response to radiation therapy and/or cisplatin-based chemotherapy.
  • However, discrepancies between the genetic alterations and immunoprofiles of mediastinal and testicular seminomas have been reported, raising the question of whether techniques that are useful in the diagnosis of gonadal seminoma are applicable to its mediastinal counterpart.
  • Lymphocytic infiltration was found in all 23 cases (100%).
  • The incidence of other histologic characteristics were as follows: fibrous septa/stroma (21 cases, 91%), prominent tumor cell nucleoli (21 cases, 91%), clear tumor cell cytoplasm (20 cases, 87%), distinct tumor cell borders (20 cases, 87%), granulomatous inflammation (17 cases, 74%), cellular pleomorphism (10 cases, 43%), necrosis (8 cases, 35%), prominent cystic change (2 cases, 8%), intercellular edema (1 case, 4%), and syncytiotrophoblasts (1 case, 4%).
  • Lymphocytic infiltration is the most common histologic feature observed in primary mediastinal seminoma and both OCT4 immunostain and FISH for 12p abnormalities can be very helpful in diagnosing mediastinal seminoma.
  • [MeSH-minor] Adolescent. Adult. Biomarkers, Tumor / analysis. Chromosome Aberrations. Female. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Male. Middle Aged. Neoplasms, Germ Cell and Embryonal / genetics. Neoplasms, Germ Cell and Embryonal / pathology. Octamer Transcription Factor-3 / biosynthesis

  • Genetic Alliance. consumer health - Seminoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18162782.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Octamer Transcription Factor-3; 0 / POU5F1 protein, human
  •  go-up   go-down


14. Davern S, Tang LX, Williams TK, Macy SD, Wall JS, Weiss DT, Solomon A: Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies. Am J Clin Pathol; 2008 Nov;130(5):702-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Because these components serve as unique cellular and serologic biomarkers, their detection and quantitation has diagnostic, therapeutic, and prognostic import.
  • Our anti-FLC mAbs, with their high degree of reactivity and versatility, may provide an invaluable tool in the diagnosis and management of light chain-associated disease.

  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Chem. 2001 Apr;47(4):673-80 [11274017.001]
  • [Cites] Br J Haematol. 2008 May;141(4):413-22 [18318757.001]
  • [Cites] Blood. 2001 May 1;97(9):2900-2 [11313287.001]
  • [Cites] Am J Clin Pathol. 2001 Jul;116(1):135-42 [11447744.001]
  • [Cites] Clin Chem. 2002 Sep;48(9):1437-44 [12194920.001]
  • [Cites] Am J Clin Pathol. 2003 Feb;119(2):274-8 [12579999.001]
  • [Cites] J Immunol Methods. 2003 Apr 1;275(1-2):9-17 [12667666.001]
  • [Cites] Br J Haematol. 2003 Jul;122(1):78-84 [12823348.001]
  • [Cites] Br J Haematol. 2004 Aug;126(3):348-54 [15257706.001]
  • [Cites] Blood. 2004 Aug 1;104(3):829-31 [15090444.001]
  • [Cites] Br J Haematol. 2004 Nov;127(3):308-10 [15491291.001]
  • [Cites] J Biol Chem. 1969 Jun 25;244(12):3393-404 [4183096.001]
  • [Cites] Immunochemistry. 1970 Aug;7(8):709-13 [4098901.001]
  • [Cites] Science. 1973 Feb 9;179(4073):580-2 [4119686.001]
  • [Cites] Scand J Immunol. 1976;5(6-7):685-95 [62385.001]
  • [Cites] Clin Exp Immunol. 1983 Apr;52(1):234-40 [6190595.001]
  • [Cites] Methods Enzymol. 1985;116:101-21 [3937021.001]
  • [Cites] J Immunol Methods. 1987 May 4;99(1):141-7 [3106501.001]
  • [Cites] Am J Pathol. 1990 Oct;137(4):855-62 [2121042.001]
  • [Cites] Br J Haematol. 1992 Jun;81(2):223-30 [1643019.001]
  • [Cites] Am J Clin Pathol. 1993 Jul;100(1):67-74 [7688492.001]
  • [Cites] Semin Hematol. 1995 Jan;32(1):45-59 [7878478.001]
  • [Cites] Clin Exp Immunol. 1998 Feb;111(2):457-62 [9486419.001]
  • [Cites] Arch Biochem Biophys. 1962 Sep;Suppl 1:174-80 [13945475.001]
  • [Cites] Br J Haematol. 2005 Feb;128(3):405-6; author reply 406-7 [15667546.001]
  • [Cites] Blood. 2006 May 15;107(10):3854-8 [16434487.001]
  • [Cites] Clin Chem Lab Med. 2006;44(5):522-32 [16681419.001]
  • [Cites] Methods Enzymol. 2006;412:48-62 [17046651.001]
  • [Cites] Clin Chim Acta. 2007 Feb;376(1-2):30-6 [16945362.001]
  • [Cites] Intern Med J. 2007 Jul;37(7):456-63 [17547724.001]
  • [Cites] Blood. 2007 Aug 1;110(3):827-32 [17416735.001]
  • [Cites] Clin Chem. 2007 Nov;53(11):1985-6 [17954504.001]
  • [Cites] Blood. 2008 Jan 15;111(2):785-9 [17942755.001]
  • [CommentIn] Am J Clin Pathol. 2009 Jun;131(6):901-2; author reply 902-3 [19461100.001]
  • (PMID = 18854262.001).
  • [ISSN] 1943-7722
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA010056-41; United States / NCI NIH HHS / CA / R01 CA010056; United States / NCI NIH HHS / CA / CA10056; United States / NCI NIH HHS / CA / R01 CA010056-41
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Immunoglobulin Light Chains; 0 / Immunoglobulin kappa-Chains; 0 / Immunoglobulin lambda-Chains; 9006-99-9 / Bence Jones Protein
  • [Other-IDs] NLM/ NIHMS75888; NLM/ PMC2620173
  •  go-up   go-down


15. Briñas L, Richard P, Quijano-Roy S, Gartioux C, Ledeuil C, Lacène E, Makri S, Ferreiro A, Maugenre S, Topaloglu H, Haliloglu G, Pénisson-Besnier I, Jeannet PY, Merlini L, Navarro C, Toutain A, Chaigne D, Desguerre I, de Die-Smulders C, Dunand M, Echenne B, Eymard B, Kuntzer T, Maincent K, Mayer M, Plessis G, Rivier F, Roelens F, Stojkovic T, Taratuto AL, Lubieniecki F, Monges S, Tranchant C, Viollet L, Romero NB, Estournet B, Guicheney P, Allamand V: Early onset collagen VI myopathies: Genetic and clinical correlations. Ann Neurol; 2010 Oct;68(4):511-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We extensively characterized, at the clinical, cellular, and molecular levels, 49 patients with onset in the first 2 years of life to investigate genotype-phenotype correlations.
  • INTERPRETATION: This work emphasizes that the diagnosis of early onset ColVI myopathies is arduous and time-consuming, and demonstrates that quantitative RT-PCR is a helpful tool for the identification of some mutation-bearing genes.
  • [MeSH-minor] Adolescent. Adult. Cells, Cultured. Child. Child, Preschool. Europe. Female. Fibroblasts / metabolism. Genetic Testing / methods. Glycine / genetics. Humans. Male. Muscle, Skeletal / metabolism. Phenotype. Young Adult

  • MedlinePlus Health Information. consumer health - Health Statistics.
  • MedlinePlus Health Information. consumer health - Muscle Disorders.
  • Hazardous Substances Data Bank. GLYCINE .
  • SciCrunch. Clinical Genomic Database: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20976770.001).
  • [ISSN] 1531-8249
  • [Journal-full-title] Annals of neurology
  • [ISO-abbreviation] Ann. Neurol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Collagen Type VII; TE7660XO1C / Glycine
  •  go-up   go-down


16. Franco R, Esposito F, Fedele M, Liguori G, Pierantoni GM, Botti G, Tramontano D, Fusco A, Chieffi P: Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours. J Pathol; 2008 Jan;214(1):58-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They are abundantly expressed during embryogenesis and in most malignant neoplasias, whereas their expression is low or absent in normal adult tissues.
  • Their over-expression is known to have a causal role in cellular neoplastic transformation.
  • These findings indicate that HMGA1 and HMGA2 are differently expressed with respect to the state of differentiation of testicular germ cell tumours (TGCTs), with over-expression of both proteins in pluripotential embryonal carcinoma cells and loss of expression of HMGA1 in yolk sac tumours and of both proteins in the mature adult tissue of teratoma areas.
  • Therefore, the different profiles of HMGA1 and HMGA2 protein expression could represent a valuable diagnostic tool in some cases in which the histological differential diagnosis is problematic.
  • [MeSH-major] Biomarkers, Tumor / metabolism. HMGA1a Protein / metabolism. HMGA2 Protein / metabolism. Neoplasms, Germ Cell and Embryonal / diagnosis. Testicular Neoplasms / diagnosis
  • [MeSH-minor] Adult. Blotting, Western. Gene Expression. Humans. Immunoenzyme Techniques. Male. Middle Aged. Neoplasm Proteins / genetics. Neoplasm Proteins / metabolism. RNA, Messenger / genetics. RNA, Neoplasm / genetics. Reverse Transcriptase Polymerase Chain Reaction / methods

  • MedlinePlus Health Information. consumer health - Testicular Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17935122.001).
  • [ISSN] 0022-3417
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / HMGA2 Protein; 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 124544-67-8 / HMGA1a Protein
  •  go-up   go-down


17. Wu XY, Yi XH, Li HP, Luo BF, Li X, Wang YL, Zeng Y, Rui WW, Zhu XY, Li XJ: [A study on the efficacy of glucocorticoid therapy for idiopathic nonspecific interstitial pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi; 2010 Aug;33(8):593-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Twenty-nine cases of INSIP confirmed by clinical- radiological-pathological (CRP) diagnosis were collected and classified into 2 groups according to the degree of fibrosis: INSIP-1 (including 9 cases of cellular type) and INSIP-2 (20 cases of mixed and fibrotic type).
  • Thirty cases of usual interstitial pneumonia (UIP) confirmed by CRP diagnosis served as the control.
  • The cellular type has a favorable reaction to glucocorticoid therapy and a better prognosis as compared to the fibrotic type.
  • [MeSH-minor] Adult. Aged. Female. Fibrosis. Humans. Lung / pathology. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Steroids.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20979847.001).
  • [ISSN] 1001-0939
  • [Journal-full-title] Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
  • [ISO-abbreviation] Zhonghua Jie He He Hu Xi Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Glucocorticoids
  •  go-up   go-down


18. Osborn M, Aqel N, Levine TS: The fine needle aspiration appearances of Kikuchi's lymphadenitis. Cytopathology; 2009 Feb;20(1):36-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In eight cases the original prospective diagnosis of necrotizing non-granulomatous lymphadenitis consistent with KD had been suggested on the lymph node aspirate.
  • CONCLUSION: The accurate diagnosis of KD on fine needle aspiration is possible given correct clinical data, an adequately sampled and well-prepared specimen in which the characteristic intra- and extracellular apoptotic nuclear debris with admixed crescentic macrophages are identified on a reactive lymphoid background.
  • [MeSH-minor] Adolescent. Adult. Female. Humans. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17916091.001).
  • [ISSN] 1365-2303
  • [Journal-full-title] Cytopathology : official journal of the British Society for Clinical Cytology
  • [ISO-abbreviation] Cytopathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


19. Burton CM, Iversen M, Carlsen J, Mortensen J, Andersen CB, Steinbrüchel D, Scheike T: Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1. J Heart Lung Transplant; 2009 Sep;28(9):888-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
  • Acute cellular rejection was independently associated with an increased cause-specific hazard of BOS (hazard ratio 1.4, confidence interval 1.1 to 1.8, p = 0.009).
  • CONCLUSION: Despite early diagnosis and prompt treatment, acute cellular rejection remains an independent risk factor for the development of BOS after adjusting for the confounding of post-transplant baseline FEV(1).
  • [MeSH-minor] Adult. Death. Female. Heart-Lung Transplantation / adverse effects. Heart-Lung Transplantation / pathology. Humans. Incidence. Lung Diseases / classification. Lung Diseases / surgery. Male. Middle Aged. Retrospective Studies. Risk Factors. Survival Analysis. Survivors. Time Factors

  • Genetic Alliance. consumer health - Bronchiolitis Obliterans.
  • MedlinePlus Health Information. consumer health - Lung Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19716040.001).
  • [ISSN] 1557-3117
  • [Journal-full-title] The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • [ISO-abbreviation] J. Heart Lung Transplant.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


20. Martins RH, Dias NH, Santos DC, Fabro AT, Braz JR: Clinical, histological and electron microscopic aspects of vocal fold granulomas. Braz J Otorhinolaryngol; 2009 Jan-Feb;75(1):116-22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We analyzed: age, gender, indication and time of intubation, symptoms, videolaryngoscopic diagnosis and biopsy findings.
  • Morphological alterations occur in the corion as vessel proliferations, inflammation, and intracytoplasmatic alterations in fibroblasts suggesting cellular dysfunction and damage.
  • [MeSH-minor] Adolescent. Adult. Aged. Child, Preschool. Female. Humans. Male. Microscopy, Electron. Middle Aged. Retrospective Studies. Young Adult

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19488571.001).
  • [ISSN] 1808-8694
  • [Journal-full-title] Brazilian journal of otorhinolaryngology
  • [ISO-abbreviation] Braz J Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


21. Suzuki H, Toba K, Kato K, Ozawa T, Tomosugi N, Higuchi M, Kusuyama T, Iso Y, Kobayashi N, Yokoyama S, Fukuda N, Saitoh H, Akazawa K, Aizawa Y: Serum hepcidin-20 is elevated during the acute phase of myocardial infarction. Tohoku J Exp Med; 2009 Jun;218(2):93-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serum hepcidin-20 is elevated during the acute phase of myocardial infarction.
  • Hepcidin, a key iron-regulator secreted from the liver, consists of 25 amino acids (hepcidin-25), blocks iron release from macrophages via internalization and degradation of cellular iron exporter ferroportin, and restrains the use of iron in organs.
  • Here, we successfully measured the serum levels of hepcidin-25 and hepcidin-20 in 12 patients with acute myocardial infarction (AMI) using surface-enhanced laser desorption ionization time of flight mass spectrometry.
  • In conclusion, the serum hepcidin-20 is transiently elevated in response to acute cardiac ischemia.
  • Measurement of serum hepcidin-20, rather than hepcidin-25, is helpful for diagnosis of acute myocardial infarction.
  • [MeSH-minor] Acute Disease. Adult. Aged. Amino Acid Sequence. Biomarkers / blood. C-Reactive Protein / metabolism. Creatine Kinase / blood. Erythropoietin / administration & dosage. Erythropoietin / pharmacology. Female. Hepcidins. Humans. Inflammation / blood. Insulin / chemistry. Interleukin-6 / blood. Male. Middle Aged. Molecular Sequence Data. Sequence Homology, Amino Acid. Time Factors

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19478464.001).
  • [ISSN] 1349-3329
  • [Journal-full-title] The Tohoku journal of experimental medicine
  • [ISO-abbreviation] Tohoku J. Exp. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antimicrobial Cationic Peptides; 0 / Biomarkers; 0 / HAMP protein, human; 0 / Hepcidins; 0 / Insulin; 0 / Interleukin-6; 0 / Peptide Fragments; 0 / hepcidin (6-25), human; 11096-26-7 / Erythropoietin; 9007-41-4 / C-Reactive Protein; EC 2.7.3.2 / Creatine Kinase
  •  go-up   go-down


22. Styczynski J, Wysocki M, Debski R, Czyzewski K, Kolodziej B, Rafinska B, Kubicka M, Koltan S, Koltan A, Pogorzala M, Kurylak A, Olszewska-Slonina D, Balwierz W, Juraszewska E, Wieczorek M, Olejnik I, Krawczuk-Rybak M, Kuzmicz M, Kowalczyk J, Stefaniak J, Badowska W, Sonta-Jakimczyk D, Szczepanski T, Matysiak M, Malinowska I, Stanczak E, Wachowiak J, Konatkowska B, Gil L, Balcerska A, Maciejka-Kapuscinska L: Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia. J Cancer Res Clin Oncol; 2007 Nov;133(11):875-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
  • PURPOSE: Cellular resistance in childhood acute leukemias might be related to profile and function of multidrug resistance proteins and apoptosis regulating proteins.
  • (2) correlation with ex vivo drug resistance, and (3) analysis of their prognostic impact on clinical outcome in childhood acute lymphoblastic (ALL) and acute myeloid (AML) leukemia.
  • CONCLUSIONS: The phenomenon of cellular drug resistance in childhood acute leukemias is multifactorial and plays an important role in response to therapy.
  • [MeSH-major] Drug Resistance, Multiple. Drug Resistance, Neoplasm. Multidrug Resistance-Associated Proteins / metabolism. P-Glycoprotein / metabolism. Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism. Vault Ribonucleoprotein Particles / metabolism
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Agents / pharmacology. Child. Child, Preschool. Female. Flow Cytometry. Gene Expression Regulation, Leukemic. Humans. Immunophenotyping. Infant. Infant, Newborn. Male. Neoplasm Recurrence, Local / diagnosis. Prognosis

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia, Childhood.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] J Cancer Res Clin Oncol. 2007 Nov;133(11):895. Wachowiak, Jacek [added]; Konatkowska, Benigna [added]; Gil, Lidia [added]; Balcerska, Anna [added]; Maciejka-Kapuscinska, Lucyna [added]
  • [Cites] Med Pediatr Oncol. 2002 Jun;38(6):379-86 [11984797.001]
  • [Cites] Leukemia. 2003 Aug;17(8):1566-72 [12886244.001]
  • [Cites] Anticancer Res. 2005 May-Jun;25(3B):2253-8 [16158972.001]
  • [Cites] Clin Cancer Res. 2001 Oct;7(10):3120-6 [11595704.001]
  • [Cites] J Pediatr Hematol Oncol. 2000 Jan-Feb;22(1):45-9 [10695821.001]
  • [Cites] Blood. 2002 Nov 1;100(9):3352-60 [12384437.001]
  • [Cites] Leukemia. 1994 Jul;8(7):1224-9 [8035616.001]
  • [Cites] Leukemia. 2005 Dec;19(12):2125-9 [16281077.001]
  • [Cites] Leuk Lymphoma. 2003 Jan;44(1):85-95 [12691146.001]
  • [Cites] Blood. 1998 Mar 15;91(6):2092-8 [9490695.001]
  • [Cites] Br J Haematol. 1998 Aug;102(3):647-55 [9722289.001]
  • [Cites] Leukemia. 1995 Nov;9(11):1864-9 [7475276.001]
  • [Cites] Blood. 2003 Dec 15;102(13):4493-8 [12816874.001]
  • [Cites] Br J Haematol. 2004 Nov;127(3):264-79 [15491285.001]
  • [Cites] J Clin Oncol. 2004 Mar 1;22(5):963-4 [14990658.001]
  • [Cites] Pediatr Int. 1999 Dec;41(6):641-7 [10618884.001]
  • [Cites] Blood. 1995 Nov 15;86(10):3861-8 [7579354.001]
  • [Cites] Leukemia. 1999 Dec;13(12):2023-30 [10602424.001]
  • [Cites] Pediatr Blood Cancer. 2004 Feb;42(2):195-9 [14752887.001]
  • [Cites] Blood. 2000 Oct 15;96(8):2879-86 [11023525.001]
  • [Cites] Zhonghua Nei Ke Za Zhi. 1999 Nov;38(11):760-3 [11798719.001]
  • [Cites] Blood. 1997 Oct 1;90(7):2723-9 [9326239.001]
  • [Cites] Klin Padiatr. 2005 Nov-Dec;217(6):310-20 [16307416.001]
  • [Cites] Leuk Lymphoma. 2002 Sep;43(9):1843-8 [12685842.001]
  • [Cites] Clin Cancer Res. 2003 Mar;9(3):1083-6 [12631611.001]
  • [Cites] Br J Haematol. 1999 Jun;105(4):876-82 [10554796.001]
  • [Cites] Leukemia. 2005 Dec;19(12):2025-9 [16304569.001]
  • [Cites] Leuk Lymphoma. 1994 Apr;13(3-4):187-201 [8049644.001]
  • [Cites] Int J Clin Pharmacol Ther. 2000 Mar;38(3):94-110 [10739113.001]
  • [Cites] Klin Padiatr. 1987 May-Jun;199(3):151-60 [3306129.001]
  • [Cites] Leukemia. 2005 Dec;19(12):2117-24 [16107894.001]
  • [Cites] J Clin Oncol. 2003 Sep 1;21(17):3262-8 [12947061.001]
  • [Cites] N Engl J Med. 2000 Apr 6;342(14):998-1006 [10749961.001]
  • [Cites] Lancet. 1998 Nov 28;352(9142):1731-8 [9848348.001]
  • [Cites] J Clin Oncol. 2005 Nov 1;23(31):7942-50 [16258094.001]
  • [Cites] Curr Opin Oncol. 1995 Jan;7(1):36-44 [7696362.001]
  • [Cites] Blood. 2003 Oct 1;102(7):2387-94 [12816873.001]
  • [Cites] Expert Rev Mol Diagn. 2004 Sep;4(5):705-13 [15347263.001]
  • [Cites] J Endocrinol. 2003 Jul;178(1):19-27 [12844332.001]
  • [Cites] N Engl J Med. 2006 Jan 12;354(2):166-78 [16407512.001]
  • [Cites] Zhonghua Nei Ke Za Zhi. 2002 Mar;41(3):183-5 [11940320.001]
  • [Cites] Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8661-8 [16361551.001]
  • [Cites] Int J Cancer. 1999 Aug 12;82(4):599-604 [10404077.001]
  • [Cites] Sao Paulo Med J. 2004 Jul 1;122(4):166-71 [15543372.001]
  • [Cites] Leuk Lymphoma. 2002 Apr;43(4):875-9 [12153178.001]
  • [Cites] Leukemia. 2000 Dec;14(12):2205-22 [11187912.001]
  • [Cites] Cancer Cell. 2002 Mar;1(2):133-43 [12086872.001]
  • [Cites] Ai Zheng. 2005 Aug;24(8):1015-7 [16086885.001]
  • [Cites] Exp Hematol. 1998 Nov;26(12):1111-7 [9808049.001]
  • [Cites] Leukemia. 2005 Dec;19(12):2063-71 [16107896.001]
  • [Cites] Br J Haematol. 1999 Feb;104(2):321-7 [10050715.001]
  • [Cites] Exp Hematol. 2002 Nov;30(11):1302-8 [12423683.001]
  • [Cites] Blood. 2000 Jun 1;95(11):3310-22 [10828010.001]
  • (PMID = 17671794.001).
  • [ISSN] 0171-5216
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Multidrug Resistance-Associated Proteins; 0 / P-Glycoprotein; 0 / Vault Ribonucleoprotein Particles; 0 / major vault protein
  •  go-up   go-down


23. António N, Prieto D, Antunes MJ: Uric acid: a prognostic marker not only before but also after heart transplantation. Eur J Cardiothorac Surg; 2010 Aug;38(2):187-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: Early diagnosis of rejection after heart transplantation is mandatory, since even mild rejection can rapidly progress to more severe rejection.
  • However, the identification of patients at high risk of acute cellular rejection and their non-invasive diagnosis remains a challenge.
  • To identify patients with a high risk of acute cellular rejection during the first post-transplantation year.
  • Uric acid levels higher than 7.2 mg dl(-1) were identified as the optimal cut-off value to predict acute rejection after heart transplantation (with a sensitivity of 71%, a specificity of 62% and an area under the curve of 0.64).
  • CONCLUSIONS: Our work suggests that hyperuricaemia may be a marker of acute cellular rejection that could be another tool helping to identify acute rejection during the follow-up of cardiac-transplanted patients.
  • [MeSH-major] Graft Rejection / diagnosis. Heart Transplantation. Uric Acid / blood
  • [MeSH-minor] Acute Disease. Adult. Aged. Biomarkers / blood. Early Diagnosis. Epidemiologic Methods. Female. Humans. Hyperuricemia / etiology. Male. Middle Aged. Perioperative Care / methods. Prognosis. Young Adult

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Heart Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
  • (PMID = 20185326.001).
  • [ISSN] 1873-734X
  • [Journal-full-title] European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • [ISO-abbreviation] Eur J Cardiothorac Surg
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers; 268B43MJ25 / Uric Acid
  •  go-up   go-down


24. Accomando S, Montaperto D, Fragapane ML, Amato GM, Corsello G, Cappello F, Maresi E: An interesting question of Pompe disease. A case report. Minerva Pediatr; 2005 Dec;57(6):423-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Glycogenosis type II or Pompe disease is an inherited autosomal recessive disorder known in 3 different clinical forms (infantile, juvenile and adult).
  • The clinical diagnosis of infantile Pompe disease was confirmed by the almost total absence of cellular acid a-glucosidase activity but we couldn't perform the assay because of the rapid exitus of our patient, which occurred before glycogen storage disease II was suspected.
  • The contribution of genetic counseling practiced on all the couples at risk remains useful every time that a certain diagnosis is made.


25. Cho CK, Shan SJ, Winsor EJ, Diamandis EP: Proteomics analysis of human amniotic fluid. Mol Cell Proteomics; 2007 Aug;6(8):1406-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These data will contribute to the better understanding of amniotic fluid function and to the discovery of novel biomarkers for prenatal diagnosis of fetal abnormalities.
  • [MeSH-minor] Adult. Chromatography, Liquid / methods. Electrophoresis, Gel, Two-Dimensional / methods. Female. Humans. Middle Aged. Pregnancy. Tandem Mass Spectrometry / methods

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17495049.001).
  • [ISSN] 1535-9476
  • [Journal-full-title] Molecular & cellular proteomics : MCP
  • [ISO-abbreviation] Mol. Cell Proteomics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteome
  •  go-up   go-down


26. Tse GM, Ma TK, Lui PC, Ng DC, Yu AM, Vong JS, Niu Y, Chaiwun B, Lam WW, Tan PH: Fine needle aspiration cytology of papillary lesions of the breast: how accurate is the diagnosis? J Clin Pathol; 2008 Aug;61(8):945-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine needle aspiration cytology of papillary lesions of the breast: how accurate is the diagnosis?
  • BACKGROUND: Cytological diagnosis of mammary papillary lesions is difficult.
  • AIM: To review the previous cytology diagnosis of 23 papillomas and 11 papillary carcinomas and specific cytological features that may assist in differentiating these entities.
  • CONCLUSION: Cytological diagnosis of papillary lesions shows a significant error rate with overlapping features.
  • Cellular atypia and fragments with long and slender papillae with ramifying edges favour papillary carcinoma.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biopsy, Needle. Diagnosis, Differential. Female. Humans. Middle Aged. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18552172.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  •  go-up   go-down


27. Celis JE, Cabezón T, Moreira JM, Gromov P, Gromova I, Timmermans-Wielenga V, Iwase T, Akiyama F, Honma N, Rank F: Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Mol Oncol; 2009 Jun;3(3):220-37
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Invasive apocrine carcinomas (IACs), as defined by morphological features, correspond to 0.3-4% of all invasive ductal carcinomas (IDC), and despite the fact that they are histologically distinct from other breast lesions there are currently no standard molecular criteria available for their diagnosis and no unequivocal information as to their prognosis.
  • Samples were originally classified on the basis of cellular morphology with all cases having more than 90% of the tumour cells exhibiting cytological features typical of apocrine cells.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Gene Expression Profiling. Humans. Immunohistochemistry. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Pathol. 2007 Dec;60(12):1313-20 [18042688.001]
  • [Cites] Acta Oncol. 2006;45(6):643-61 [16938807.001]
  • [Cites] Mod Pathol. 1994 Oct;7(8):813-8 [7838835.001]
  • [Cites] Biotechnol Annu Rev. 2008;14:143-70 [18606362.001]
  • [Cites] Am J Pathol. 1983 Feb;110(2):105-12 [6130702.001]
  • [Cites] Hum Pathol. 2007 Feb;38(2):197-204 [17234468.001]
  • [Cites] Pathol Biol (Paris). 2009 Jun;57(4):324-33 [19070972.001]
  • [Cites] J Pathol. 2006 Mar;208(4):495-506 [16429394.001]
  • [Cites] J Biol Chem. 2002 May 24;277(21):18649-57 [11901151.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):555-69 [15644556.001]
  • [Cites] Breast. 2005 Feb;14(1):3-10 [15695074.001]
  • [Cites] Eur J Cancer. 2008 Dec;44(18):2799-805 [19008097.001]
  • [Cites] Tissue Eng Part C Methods. 2008 Sep;14(3):261-71 [18694322.001]
  • [Cites] Clin Cancer Res. 2004 Aug 15;10(16):5367-74 [15328174.001]
  • [Cites] J Clin Pathol. 2007 Sep;60(9):1006-12 [17105822.001]
  • [Cites] Nat Clin Pract Oncol. 2008 Mar;5(3):149-59 [18212769.001]
  • [Cites] Curr Opin Biotechnol. 1999 Feb;10(1):16-21 [10047502.001]
  • [Cites] Mol Oncol. 2008 Dec;2(4):368-79 [19383358.001]
  • [Cites] Nature. 2000 Aug 17;406(6797):747-52 [10963602.001]
  • [Cites] Cancer Cell. 2006 Dec;10(6):529-41 [17157792.001]
  • [Cites] Nature. 2002 Jan 31;415(6871):530-6 [11823860.001]
  • [Cites] Lancet Oncol. 2007 Mar;8(3):235-44 [17329194.001]
  • [Cites] Eur J Cancer. 2005 Sep;41(13):1854-63 [16002278.001]
  • [Cites] Breast J. 2008 Mar-Apr;14(2):164-8 [18248561.001]
  • [Cites] Breast Cancer Res. 2008;10(3):R53 [18559090.001]
  • [Cites] Mol Oncol. 2008 Oct;2(3):213-22 [19383342.001]
  • [Cites] Pathol Res Pract. 2005;201(7):479-86 [16164042.001]
  • [Cites] Mol Cell Proteomics. 2008 Oct;7(10):1795-809 [18632593.001]
  • [Cites] Histopathology. 2007 Mar;50(4):425-33 [17448017.001]
  • [Cites] Cancer. 1980 Dec 1;46(11):2463-71 [6254632.001]
  • [Cites] Prostaglandins Leukot Essent Fatty Acids. 2002 Dec;67(6):461-5 [12468268.001]
  • [Cites] Med Oncol. 1997 Jun;14(2):83-9 [9330267.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23 [12829800.001]
  • [Cites] Br J Cancer. 2006 Aug 7;95(3):339-46 [16892043.001]
  • [Cites] Br J Cancer. 2003 Jan 27;88(2):231-6 [12610508.001]
  • [Cites] FEBS Lett. 2006 May 22;580(12):2935-44 [16631754.001]
  • [Cites] Cancer Res. 2004 Feb 1;64(3):830-5 [14871808.001]
  • [Cites] Oncogene. 2005 Jul 7;24(29):4660-71 [15897907.001]
  • [Cites] Nat Methods. 2007 Apr;4(4):359-65 [17396127.001]
  • [Cites] Mol Cell Proteomics. 2006 Mar;5(3):462-83 [16316978.001]
  • [Cites] Histopathology. 2005 Aug;47(2):195-201 [16045781.001]
  • [Cites] Nat Rev Cancer. 2005 Dec;5(12):930-42 [16341084.001]
  • [Cites] Mol Oncol. 2009 Feb;3(1):24-32 [19383364.001]
  • [Cites] Pathol Res Pract. 1997;193(11-12):753-8 [9521507.001]
  • [Cites] J Pathol. 2008 Oct;216(2):141-50 [18720457.001]
  • [Cites] Cancer. 1968 Apr;21(4):756-63 [4296681.001]
  • [Cites] Annu Rev Genomics Hum Genet. 2001;2:343-72 [11701654.001]
  • [Cites] Am J Surg Pathol. 2003 Jun;27(6):832-5 [12766589.001]
  • [Cites] N Engl J Med. 2004 Dec 30;351(27):2817-26 [15591335.001]
  • [Cites] Histopathology. 2008 Jan;52(1):108-18 [18171422.001]
  • [Cites] Expert Opin Drug Metab Toxicol. 2008 Nov;4(11):1391-402 [18950281.001]
  • [Cites] Am J Pathol. 1986 Jun;123(3):532-41 [3717305.001]
  • [Cites] Mol Oncol. 2007 Dec;1(3):321-49 [19383306.001]
  • [Cites] Mol Oncol. 2007 Jun;1(1):97-119 [19383289.001]
  • [Cites] Histopathology. 2008 Jan;52(1):3-10 [18171412.001]
  • [Cites] J Clin Pathol. 1999 Nov;52(11):838-41 [10690175.001]
  • [Cites] Nature. 2003 Mar 13;422(6928):198-207 [12634793.001]
  • [Cites] Pathobiology. 2008;75(2):119-31 [18544967.001]
  • [Cites] Mol Oncol. 2009 Jun;3(3):220-37 [19393583.001]
  • [Cites] Nat Cell Biol. 2007 Feb;9(2):201-9 [17187062.001]
  • [Cites] Mol Oncol. 2007 Jun;1(1):42-54 [19383286.001]
  • [Cites] J Gastrointest Cancer. 2007;38(2-4):78-82 [19031117.001]
  • [Cites] Breast J. 2003 Jul-Aug;9(4):335-6 [12846876.001]
  • [Cites] Pathology. 2009 Jan;41(1):68-76 [19089742.001]
  • [Cites] N Engl J Med. 2002 Dec 19;347(25):1999-2009 [12490681.001]
  • [Cites] Nature. 2005 Sep 22;437(7058):491-3 [16177777.001]
  • [Cites] Eur J Cancer Clin Oncol. 1988 Feb;24(2):223-8 [3356211.001]
  • [Cites] Nat Clin Pract Urol. 2008 Jul;5(7):376-87 [18542103.001]
  • [Cites] Cancer Res. 2005 Sep 1;65(17):7917-25 [16140963.001]
  • [Cites] Mol Oncol. 2009 Feb;3(1):33-44 [19383365.001]
  • [Cites] Breast. 2005 Feb;14(1):1-2 [15695073.001]
  • [Cites] Breast Cancer Res. 2007;9(3):R30 [17504517.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74 [11553815.001]
  • [Cites] Int J Clin Pract. 2008 Mar;62(3):444-9 [18194278.001]
  • [Cites] Mol Oncol. 2007 Sep;1(2):144-59 [18443658.001]
  • [Cites] Cell. 2006 Dec 1;127(5):1041-55 [17129787.001]
  • [Cites] JAMA. 2006 Jun 7;295(21):2492-502 [16757721.001]
  • [Cites] J Cell Biochem. 2007 Oct 15;102(3):580-92 [17668425.001]
  • [Cites] Mol Oncol. 2007 Jun;1(1):84-96 [18516279.001]
  • (PMID = 19393583.001).
  • [ISSN] 1878-0261
  • [Journal-full-title] Molecular oncology
  • [ISO-abbreviation] Mol Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


28. Simionescu C, Georgescu CV, Mărgăritescu C, Niculescu M: Diagnosis problems in a case of minimal deviation adenocarcinoma of the cervix. Rom J Morphol Embryol; 2006;47(3):245-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis problems in a case of minimal deviation adenocarcinoma of the cervix.
  • Histopathologic exam of the tumor, made on serial sections, revealed a dense and profound proliferation of the glandular structures that were lined by endocervical type epithelia with minimal cellular and nuclear atypia.
  • The aspect suggested the diagnosis of minimal deviation adenocarcinoma endocervical type; in order to confirm the diagnosis we immunohistochemical investigate the tumor for CEA, CA125, Ki67, ER and PR.
  • We can conclude that all these markers are useful in the diagnosis, excluding the benign endocervical lesions.
  • [MeSH-major] Adenocarcinoma / diagnosis. Uterine Cervical Neoplasms / diagnosis
  • [MeSH-minor] Adult. CA-125 Antigen / analysis. Carcinoembryonic Antigen / analysis. Female. Humans. Ki-67 Antigen / analysis


29. Arista-Nasr J, Fernández-Amador JA, Martínez-Benítez B, de Anda-González J, Bornstein-Quevedo L: Neuroendocrine metastatic tumors of the liver resembling hepatocellular carcinoma. Ann Hepatol; 2010 Apr-Jun;9(2):186-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In all of these neoplasms the diagnosis of endocrine tumor was confirmed by immunohistochemical studies and the following information was recorded: age, sex, radiological alterations, primary site of the NET, and follow-up.
  • The following histological data were also recorded: fibrotic stroma associated or not with the neoplastic cells, growth pattern, form of the cells, cellular size, mitotic figures, nucleomegaly, apparent nucleoli, chromatin in salt and pepper, plasmacytoid cells, intranuclear inclusions, and biliary pigment.
  • [MeSH-minor] Aged, 80 and over. Biopsy, Needle. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Mexico. Middle Aged. Predictive Value of Tests. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20526014.001).
  • [ISSN] 1665-2681
  • [Journal-full-title] Annals of hepatology
  • [ISO-abbreviation] Ann Hepatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


30. Galvão FH, Pompeu E, Panajotopoulos N, Santos VR, Bacchella T, Machado MC: Orthotopic small intestine transplantation in dogs with systemic graft drainage. Arq Gastroenterol; 2005 Jul-Sep;42(3):182-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHOD: Adult mongrel dogs from University of São Paulo Animal Facility, São Paulo, SP, Brazil, were used as donors and recipients in ten consecutives orthotopic intestinal transplantation with mesenteric-caval venous drainage.
  • Necropsy and histology of the graft confirmed the diagnosis of severe acute cellular rejection.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16200256.001).
  • [ISSN] 0004-2803
  • [Journal-full-title] Arquivos de gastroenterologia
  • [ISO-abbreviation] Arq Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


31. Franco AF, Martini D, Abensur H, Noronha IL: Proteinuria in transplant patients associated with sirolimus. Transplant Proc; 2007 Mar;39(2):449-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sirolimus (SRL) is a potent immunosuppressive drug used in organ transplantation for prophylaxis of acute allograft rejection.
  • The light microscopy of biopsies performed after the onset of proteinuria showed no specific glomerular changes, except in 2 cases wherein the diagnosis was focal segmental glomerulosclerosis.
  • [MeSH-minor] Adult. Female. Humans. Kidney Glomerulus / pathology. Male. Middle Aged


32. Dahl K, Karlsson M, Marits P, Hoffstedt A, Winqvist O, Thörn M: Metinel node--the first lymph node draining a metastasis--contains tumor-reactive lymphocytes. Ann Surg Oncol; 2008 May;15(5):1454-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The primary tumor site was colorectal cancer in seven patients, malignant melanoma in four, ovarian cancer and breast cancer in two, and one each with pancreatic cancer, cholangiocarcinoma, leiomyosarcoma, and squamous cellular cancer of the tongue.
  • [MeSH-minor] Adult. Aged. Cells, Cultured. Female. Humans. Immunoenzyme Techniques. Immunotherapy. Interferon-gamma / secretion. Lymphatic Metastasis / diagnosis. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / prevention & control. Preoperative Care. Prognosis. Radiopharmaceuticals. Rosaniline Dyes. Technetium Tc 99m Sulfur Colloid

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. C.I. FOOD BLUE 3 .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Coll Surg. 2004 Jun;198(6):884-91 [15194069.001]
  • [Cites] Contrast Media Mol Imaging. 2006 Nov-Dec;1(6):230-45 [17191764.001]
  • [Cites] Ann Surg. 1969 Mar;169(3):297-9 [5380853.001]
  • [Cites] Prog Exp Tumor Res. 1970;13:1-27 [4921480.001]
  • [Cites] N Engl J Med. 1971 Nov 18;285(21):1182-6 [4938153.001]
  • [Cites] Am J Surg. 1975 Oct;130(4):405-11 [1166931.001]
  • [Cites] Nature. 1980 Jan 10;283(5743):139-46 [6985715.001]
  • [Cites] Br J Cancer. 1983 Jan;47(1):81-9 [6571784.001]
  • [Cites] Eur J Surg Oncol. 2005 May;31(4):381-5 [15837044.001]
  • [Cites] J Clin Oncol. 2005 Oct 20;23(30):7703-20 [16157938.001]
  • [Cites] Eur Urol. 2006 Jan;49(1):59-70 [16321468.001]
  • [Cites] N Engl J Med. 2005 Dec 22;353(25):2654-66 [16371631.001]
  • [Cites] J Clin Oncol. 2006 May 10;24(14):2137-50 [16682732.001]
  • [Cites] Cancer. 1985 Apr 1;55(7):1490-4 [3978541.001]
  • [Cites] Am J Physiol. 1986 May;250(5 Pt 2):H706-10 [3706547.001]
  • [Cites] N Engl J Med. 1991 Jan 3;324(1):1-8 [1701519.001]
  • [Cites] Br J Surg. 1992 Jan;79(1):35-8 [1737270.001]
  • [Cites] Ann Thorac Surg. 1995 Dec;60(6):1623-6 [8787454.001]
  • [Cites] Cancer Res. 2004 Dec 15;64(24):9225-9 [15604296.001]
  • [Cites] Lancet. 2005 Feb 19-25;365(9460):687-701 [15721476.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • [Cites] Br J Surg. 2000 Sep;87(9):1142-55 [10971419.001]
  • [Cites] J Urol. 2001 Sep;166(3):812-5 [11490224.001]
  • [Cites] Cancer Res. 2002 Mar 15;62(6):1669-75 [11912138.001]
  • [Cites] Science. 2002 Jun 7;296(5574):1883-6 [11976409.001]
  • [Cites] Am Surg. 2002 Sep;68(9):745-50 [12356141.001]
  • [Cites] Bioessays. 2002 Nov;24(11):1030-40 [12386934.001]
  • [Cites] N Engl J Med. 2003 Jan 16;348(3):203-13 [12529460.001]
  • [Cites] Oncol Rep. 2003 Mar-Apr;10(2):315-9 [12579265.001]
  • [Cites] Surgery. 2003 Mar;133(3):300-8 [12660643.001]
  • [Cites] Cancer. 2003 Jul 15;98(2):413-23 [12872364.001]
  • [Cites] Br J Cancer. 2006 May 22;94(10):1478-84 [16641897.001]
  • [Cites] Eur Urol. 2006 Jul;50(1):83-91 [16632191.001]
  • [Cites] Ann Surg. 2006 Aug;244(2):260-4 [16858189.001]
  • [Cites] Science. 2006 Sep 29;313(5795):1960-4 [17008531.001]
  • [Cites] Br J Cancer. 2006 Nov 20;95(10):1362-6 [17088912.001]
  • [Cites] Br J Surg. 2006 Dec;93(12):1456-63 [17115389.001]
  • [Cites] Gynecol Oncol. 2004 Jul;94(1):161-6 [15262135.001]
  • (PMID = 18299934.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0 / Rosaniline Dyes; 129-17-9 / patent blue violet; 556Q0P6PB1 / Technetium Tc 99m Sulfur Colloid; 82115-62-6 / Interferon-gamma
  • [Other-IDs] NLM/ PMC2277445
  •  go-up   go-down


33. Kenny D, Chakrabarti S, Ranasinghe A, Chambers A, Martin R, Stuart G: Single-centre use of implantable loop recorders in patients with congenital heart disease. Europace; 2009 Mar;11(3):303-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Implantable loop recorders were explanted following establishment of positive diagnosis (n = 3), negative diagnosis (n = 7), and at the end of battery life (n = 4).
  • CONCLUSION: Implantable loop recorders lead to a positive or negative arrhythmic diagnosis following explantation in 71% of patients with congenital heart disease.
  • [MeSH-major] Arrhythmias, Cardiac / diagnosis. Arrhythmias, Cardiac / etiology. Electrocardiography, Ambulatory / instrumentation. Electrocardiography, Ambulatory / methods. Heart Defects, Congenital / complications. Heart Defects, Congenital / diagnosis
  • [MeSH-minor] Adolescent. Adult. Child. Female. Humans. Male. Middle Aged. Reproducibility of Results. Sensitivity and Specificity. Young Adult

  • Genetic Alliance. consumer health - Heart Disease.
  • Genetic Alliance. consumer health - Congenital Heart Defects.
  • MedlinePlus Health Information. consumer health - Arrhythmia.
  • MedlinePlus Health Information. consumer health - Congenital Heart Defects.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19153088.001).
  • [ISSN] 1532-2092
  • [Journal-full-title] Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • [ISO-abbreviation] Europace
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


34. Hirnle L, Katnik-Prastowska I: Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection. Clin Chem Lab Med; 2007;45(2):208-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The expression of cellular, fibrin, C-terminal and EDA fibronectin domains, as well as alpha2,3- and alpha2,6-linked sialic acids, and alpha1,6-, alpha1,3- and alpha1,2-linked fucoses, was determined by ELISA, using domain-specific monoclonal antibodies and specific lectins, respectively.

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Health Problems in Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17311510.001).
  • [ISSN] 1434-6621
  • [Journal-full-title] Clinical chemistry and laboratory medicine
  • [ISO-abbreviation] Clin. Chem. Lab. Med.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Fibronectins; 0 / Peptide Fragments
  •  go-up   go-down


35. Brahmbhatt S, Black GF, Carroll NM, Beyers N, Salker F, Kidd M, Lukey PT, Duncan K, van Helden P, Walzl G: Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy. Clin Exp Immunol; 2006 Nov;146(2):243-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have examined the ability of immunological biomarkers, measured at diagnosis and after 4 weeks of treatment, to predict sputum smear status at week 8.
  • At diagnosis, 4 biomarkers (sTNF-R1, total WBC, absolute monocyte and absolute neutrophil numbers) were significantly higher in slow response patients.
  • Discriminant analysis of the diagnosis and week 4 data provided models for classification of slow response patients with 67% and 83% predictive accuracy.
  • [MeSH-minor] Adult. Biomarkers / blood. Epidemiologic Methods. Female. Humans. Leukocyte Count. Male. Middle Aged. Prognosis. Sputum / microbiology. Treatment Outcome

  • Genetic Alliance. consumer health - Tuberculosis.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Exp Immunol. 2000 Oct;122(1):79-84 [11012622.001]
  • [Cites] Tuberculosis (Edinb). 2006 May-Jul;86(3-4):255-62 [16600686.001]
  • [Cites] J Immunol. 2001 Dec 15;167(12):6991-7000 [11739519.001]
  • [Cites] Clin Diagn Lab Immunol. 2002 Jul;9(4):818-23 [12093679.001]
  • [Cites] Lancet. 2002 Aug 17;360(9332):528-34 [12241657.001]
  • [Cites] Curr Opin Crit Care. 2002 Aug;8(4):321-30 [12386493.001]
  • [Cites] Nat Immunol. 2002 Nov;3(11):1061-8 [12368910.001]
  • [Cites] Clin Diagn Lab Immunol. 2003 Jan;10(1):133-9 [12522051.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4003-8 [15020765.001]
  • [Cites] J Exp Med. 1983 May 1;157(5):1483-95 [6189939.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Dec;82(24):8629-33 [2417226.001]
  • [Cites] Eur J Haematol. 1988 Nov;41(5):414-9 [2850215.001]
  • [Cites] Am J Pathol. 1989 Jun;134(6):1189-99 [2667373.001]
  • [Cites] Diagn Microbiol Infect Dis. 1990 Sep-Oct;13(5):411-21 [2126500.001]
  • [Cites] J Exp Med. 1992 Feb 1;175(2):323-9 [1310100.001]
  • [Cites] Immunol Today. 1992 May;13(5):151-3 [1322675.001]
  • [Cites] Arthritis Rheum. 1992 Oct;35(10):1160-9 [1329774.001]
  • [Cites] Curr Opin Immunol. 1993 Feb;5(1):90-6 [8452680.001]
  • [Cites] J Exp Med. 1996 May 1;183(5):2293-302 [8642338.001]
  • [Cites] Tuber Lung Dis. 1996 Aug;77(4):374-9 [8796256.001]
  • [Cites] Fetal Diagn Ther. 1996 Jul-Aug;11(4):249-53 [8823604.001]
  • [Cites] J Inflamm. 1995-1996;46(1):23-31 [8832969.001]
  • [Cites] N Engl J Med. 1996 Dec 26;335(26):1941-9 [8960473.001]
  • [Cites] Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1328-31 [9563758.001]
  • [Cites] J Immunol. 1998 May 1;160(9):4490-9 [9574555.001]
  • [Cites] Circulation. 1998 Apr 14;97(14):1382-91 [9577950.001]
  • [Cites] Pharmacol Res. 1998 Mar;37(3):219-26 [9602471.001]
  • [Cites] Scand J Immunol. 1998 Nov;48(5):535-43 [9822264.001]
  • [Cites] Clin Exp Immunol. 1999 May;116(2):263-9 [10337017.001]
  • [Cites] Clin Exp Immunol. 1999 May;116(2):299-306 [10337022.001]
  • [Cites] J Infect Dis. 2005 Jan 1;191(1):20-4 [15592998.001]
  • [Cites] Nat Biotechnol. 2005 Mar;23(3):297-304 [15765081.001]
  • [Cites] Expert Rev Proteomics. 2005 Apr;2(2):187-202 [15892564.001]
  • [Cites] Microbes Infect. 2005 Apr;7(4):776-88 [15823514.001]
  • [Cites] J Exp Med. 2005 Jun 6;201(11):1693-7 [15939785.001]
  • [Cites] Thorax. 2005 Jul;60(7):555-7 [15994262.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2005 Oct;99 Suppl 1:S15-9 [16085174.001]
  • [Cites] Appl Environ Microbiol. 2005 Oct;71(10):6086-95 [16204525.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14789-94 [16203992.001]
  • [Cites] Microbes Infect. 2006 Jan;8(1):45-51 [16269263.001]
  • [Cites] Int J Tuberc Lung Dis. 2001 Mar;5(3):283-91 [11326829.001]
  • (PMID = 17034576.001).
  • [ISSN] 0009-9104
  • [Journal-full-title] Clinical and experimental immunology
  • [ISO-abbreviation] Clin. Exp. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antitubercular Agents; 0 / Biomarkers; 0 / Cytokines
  • [Other-IDs] NLM/ PMC1942062
  •  go-up   go-down


36. Krampulz T, Hans VH, Oppel F, Dietrich U, Puchner MJ: Long-term relapse-free survival with supratentorial primitive neuroectodermal tumor in an adult: a case report. J Neurooncol; 2006 May;77(3):291-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term relapse-free survival with supratentorial primitive neuroectodermal tumor in an adult: a case report.
  • Survival longer than 15 years in an adult has only been reported once so far.
  • The original histological diagnosis was that of an undifferentiated sarcoma, malignant hemangioendothelioma, grade III.
  • Admission for another reason in 2003 led to a re-evaluation of the original diagnosis.
  • Microscopy revealed a malignant, highly cellular, poorly differentiated tumor with a desmoplastic component.
  • According to these findings, the diagnosis was changed to a sPNET (WHO IVdegrees ).
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. Diagnosis, Differential. Disease-Free Survival. Humans. Ki-67 Antigen / metabolism. Male. Receptor, Nerve Growth Factor / metabolism. Treatment Outcome

  • Genetic Alliance. consumer health - Supratentorial primitive neuroectodermal tumor.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1978 Jan;41(1):56-63 [626943.001]
  • [Cites] Med Pediatr Oncol. 2002 Sep;39(3):190-4 [12210449.001]
  • [Cites] Br J Radiol. 2003 Jan;76(901):62-5 [12595327.001]
  • [Cites] Cancer. 2001 Dec 15;92(12):3155-64 [11753995.001]
  • [Cites] Cancer. 1980 Mar 1;45(5):840-4 [7260835.001]
  • [Cites] J Clin Oncol. 2000 Mar;18(5):1027-35 [10694553.001]
  • [Cites] Pediatr Neurosurg. 1998 Oct;29(4):170-7 [9876245.001]
  • [Cites] Med Pediatr Oncol. 2001 Feb;36(2):268-73 [11452934.001]
  • [Cites] J Neurooncol. 1990 Aug;9(1):77-80 [2170592.001]
  • [Cites] Neurosurgery. 2000 Sep;47(3):623-31; discussion 631-2 [10981749.001]
  • [Cites] Acta Oncol. 2003;42(1):55-61 [12665332.001]
  • [Cites] J Neurooncol. 2001 Mar;52(1):57-62 [11451203.001]
  • [Cites] Cancer. 1999 Jul 1;86(1):142-8 [10391574.001]
  • [Cites] Surg Neurol. 1983 Jul;20(1):30-5 [6306852.001]
  • [Cites] Ann Neurol. 1996 Apr;39(4):481-9 [8619526.001]
  • [Cites] J Neurooncol. 2003 Jan;61(2):113-20 [12622449.001]
  • [Cites] J Neurosurg. 1991 Jun;74(6):905-9 [2033450.001]
  • [Cites] Br J Neurosurg. 1999 Feb;13(1):90-2 [10492697.001]
  • [Cites] Acta Cytol. 2000 Nov-Dec;44(6):1050-8 [11127734.001]
  • [Cites] J Neuropathol Exp Neurol. 1983 Jan;42(1):1-15 [6296325.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):951-7 [7607969.001]
  • [Cites] J Neurooncol. 2002 Oct;60(1):43-52 [12416545.001]
  • [Cites] J Neurooncol. 1998 Feb;36(3):259-67 [9524104.001]
  • [Cites] BMC Cancer. 2004 Jan 26;4:3 [14969593.001]
  • (PMID = 16528456.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Receptor, Nerve Growth Factor
  •  go-up   go-down


37. Moran CA, Suster S: Primary parathyroid tumors of the mediastinum: a clinicopathologic and immunohistochemical study of 17 cases. Am J Clin Pathol; 2005 Nov;124(5):749-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Six tumors were predominantly oncocytic, 6 were composed predominantly of chief cells, and 3 had mixed cellular composition.
  • The cases highlight the importance of keeping primary parathyroid tumors in the differential diagnosis of anterior mediastinal tumors.
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16203274.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Yanai H, Wani Y, Notohara K, Takada S, Yoshino T: Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review. Pathol Int; 2010 Jul;60(7):506-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Symptoms were unspecific and preoperative diagnosis of LMS had not been made.
  • Associated LM component was cellular in one case.
  • The LM component lacked p53 expression in all cases and demonstrated p16 expression in two cases, including one case of cellular LM.
  • [MeSH-minor] Adult. Cyclin-Dependent Kinase Inhibitor p16 / biosynthesis. Female. Humans. Immunohistochemistry. Ki-67 Antigen / biosynthesis. Middle Aged. Tumor Suppressor Protein p53 / biosynthesis


39. Koop O, Schirmacher A, Nelis E, Timmerman V, De Jonghe P, Ringelstein B, Rasic VM, Evrard P, Gärtner J, Claeys KG, Appenzeller S, Rautenstrauss B, Hühne K, Ramos-Arroyo MA, Wörle H, Moilanen JS, Hammans S, Kuhlenbäumer G: Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN). Neuromuscul Disord; 2007 Aug;17(8):624-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here, we report ten patients referred to us for molecular genetic diagnosis.
  • It was shown for a number of gigaxonin mutations that they impede this process leading to accumulation of microtubule associated proteins and there by impairing cellular functions.
  • [MeSH-minor] Adolescent. Adult. Child. DNA Mutational Analysis. Exons / genetics. Female. Genotype. Humans. Magnetic Resonance Imaging. Male. Microtubule-Associated Proteins / metabolism. Phenotype. Promoter Regions, Genetic / genetics. Ubiquitin / metabolism


40. Thakur N, Reddy DN, Rao GV, Mohankrishna P, Singh L, Chandak GR: A novel mutation in STK11 gene is associated with Peutz-Jeghers Syndrome in Indian patients. BMC Med Genet; 2006;7:73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Based on these results, we could offer predictive genetic testing, prenatal diagnosis and genetic counselling to other members of the family.
  • [MeSH-minor] Adult. Base Sequence. Codon, Nonsense. Endoscopy, Gastrointestinal. Family. Female. Frameshift Mutation. Gene Deletion. Humans. India. Infant. Male. Middle Aged. Phenotype. Polymerase Chain Reaction. Polyps / genetics. Polyps / pathology. Polyps / surgery. Promoter Regions, Genetic. Protein Structure, Tertiary

  • Genetic Alliance. consumer health - Peutz Jeghers syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Genet. 1998 Jan;18(1):38-43 [9425897.001]
  • [Cites] Cancer Res. 1997 Sep 1;57(17):3653-6 [9288765.001]
  • [Cites] Am J Hum Genet. 1997 Dec;61(6):1327-34 [9399902.001]
  • [Cites] Am J Hum Genet. 1998 Dec;63(6):1641-50 [9837816.001]
  • [Cites] Hum Mol Genet. 1999 May;8(5):889-97 [10196379.001]
  • [Cites] Br J Cancer. 1999 Apr;80(1-2):70-2 [10389980.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9248-51 [10430928.001]
  • [Cites] N Engl J Med. 1949 Dec 29;241(26):1031-6 [15398245.001]
  • [Cites] BMC Genomics. 2005;6:38 [15774015.001]
  • [Cites] Hum Mol Genet. 2005 May 15;14(10):1283-92 [15800014.001]
  • [Cites] Hum Mutat. 2005 Oct;26(4):291-7 [16110486.001]
  • [Cites] Hum Mutat. 2005 Dec;26(6):513-9 [16287113.001]
  • [Cites] J Med Genet. 2006 May;43(5):e18 [16648371.001]
  • [Cites] Annu Rev Biochem. 2006;75:137-63 [16756488.001]
  • [Cites] Hum Mutat. 2000;16(1):23-30 [10874301.001]
  • [Cites] Nature. 2002 Sep 12;419(6903):162-7 [12226664.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3329-35 [14985505.001]
  • [Cites] Hum Mutat. 2004 May;23(5):523-4 [15108288.001]
  • [Cites] J Med Genet. 2004 May;41(5):327-33 [15121768.001]
  • [Cites] J Biol. 2003;2(4):28 [14511394.001]
  • [Cites] Nucleic Acids Res. 1988 Feb 11;16(3):1215 [3344216.001]
  • [Cites] Science. 1988 Jul 1;241(4861):42-52 [3291115.001]
  • [Cites] J Mol Biol. 1995 Jun 23;249(5):923-32 [7791218.001]
  • [Cites] Nat Genet. 1997 Jan;15(1):87-90 [8988175.001]
  • [Cites] Nature. 1998 Jan 8;391(6663):184-7 [9428765.001]
  • (PMID = 17010210.001).
  • [ISSN] 1471-2350
  • [Journal-full-title] BMC medical genetics
  • [ISO-abbreviation] BMC Med. Genet.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Codon, Nonsense; EC 2.7.1.- / STK11 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  • [Other-IDs] NLM/ PMC1609100
  •  go-up   go-down


41. Antoni MH, Lechner S, Diaz A, Vargas S, Holley H, Phillips K, McGregor B, Carver CS, Blomberg B: Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav Immun; 2009 Jul;23(5):580-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: A diagnosis of breast cancer and treatment are psychologically stressful events, particularly over the first year after diagnosis.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Stress.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biol Blood Marrow Transplant. 1997 Apr;3(1):34-44 [9209739.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Jul;82(7):2182-91 [9215292.001]
  • [Cites] Ann Oncol. 1997 May;8(5):457-61 [9233525.001]
  • [Cites] J Natl Cancer Inst. 1998 Jan 7;90(1):30-6 [9428780.001]
  • [Cites] J Natl Cancer Inst. 1998 Feb 18;90(4):287-94 [9486814.001]
  • [Cites] Psychosom Med. 1998 May-Jun;60(3):366-71 [9625227.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7556-61 [9636188.001]
  • [Cites] Int J Cancer. 1999 Mar 15;80(6):880-8 [10074922.001]
  • [Cites] Health Psychol. 1999 Mar;18(2):159-68 [10194051.001]
  • [Cites] Psychooncology. 1999 Jan-Feb;8(1):74-91 [10202785.001]
  • [Cites] Br J Med Psychol. 1959;32(1):50-5 [13638508.001]
  • [Cites] Nat Rev Cancer. 2005 Apr;5(4):263-74 [15776005.001]
  • [Cites] J Clin Oncol. 2005 Sep 1;23(25):6083-96 [16135475.001]
  • [Cites] J Clin Oncol. 2005 Sep 1;23(25):6097-106 [16135476.001]
  • [Cites] Nat Rev Cancer. 2006 Mar;6(3):240-8 [16498446.001]
  • [Cites] Psychosom Med. 2006 May-Jun;68(3):427-36 [16738075.001]
  • [Cites] Nat Med. 2006 Aug;12(8):939-44 [16862152.001]
  • [Cites] Am J Psychiatry. 2006 Oct;163(10):1791-7 [17012691.001]
  • [Cites] J Consult Clin Psychol. 2006 Dec;74(6):1143-52 [17154743.001]
  • [Cites] Brain Behav Immun. 2007 Oct;21(7):953-61 [17467230.001]
  • [Cites] Psychosom Med. 2007 Sep-Oct;69(7):651-9 [17766693.001]
  • [Cites] Brain Behav Immun. 2007 Nov;21(8):1038-49 [17521871.001]
  • [Cites] Brain Behav Immun. 2008 Aug;22(6):969-81 [18359186.001]
  • [Cites] Psychosom Med. 2008 Nov;70(9):1044-9 [18842742.001]
  • [Cites] Tumour Biol. 1992;13(5-6):358-63 [1290032.001]
  • [Cites] J Psychosom Res. 2000 Feb;48(2):187-94 [10719136.001]
  • [Cites] Psychosom Med. 2000 May-Jun;62(3):304-8 [10845343.001]
  • [Cites] J Natl Cancer Inst. 2000 Jun 21;92(12):994-1000 [10861311.001]
  • [Cites] Blood. 2001 Jan 1;97(1):192-7 [11133760.001]
  • [Cites] Health Psychol. 2001 Jan;20(1):20-32 [11199062.001]
  • [Cites] Health Psychol. 2001 Jan;20(1):41-6 [11199065.001]
  • [Cites] Ann Intern Med. 2001 Apr 17;134(8):663-94 [11304107.001]
  • [Cites] Cytokine Growth Factor Rev. 2001 Mar;12(1):33-40 [11312117.001]
  • [Cites] Psychooncology. 2001 Nov-Dec;10(6):490-502 [11747061.001]
  • [Cites] Res Nurs Health. 2001 Aug;24(4):245-57 [11746056.001]
  • [Cites] Support Care Cancer. 2002 Mar;10(2):96-105 [11862499.001]
  • [Cites] Int J Cancer. 2002 Jul 20;100(3):347-54 [12115552.001]
  • [Cites] Brain Behav Immun. 2003 Feb;17 Suppl 1:S27-36 [12615183.001]
  • [Cites] Brain Behav Immun. 2003 Feb;17 Suppl 1:S73-83 [12615190.001]
  • [Cites] Cancer. 2003 Aug 15;98(4):854-64 [12910531.001]
  • [Cites] Psychooncology. 2003 Sep;12(6):532-46 [12923794.001]
  • [Cites] Stress. 2003 Sep;6(3):173-88 [13129811.001]
  • [Cites] Ann Surg Oncol. 2003 Oct;10(8):972-92 [14527919.001]
  • [Cites] J Psychosom Res. 2004 Jan;56(1):1-8 [14987957.001]
  • [Cites] Psychol Bull. 2004 Jul;130(4):601-30 [15250815.001]
  • [Cites] J Clin Oncol. 2004 Sep 1;22(17):3570-80 [15337807.001]
  • [Cites] Br J Psychiatry. 1967 Jan;113(494):83-8 [6029372.001]
  • [Cites] Int J Psychiatry Med. 1976-1977;7(1):1-15 [1052080.001]
  • [Cites] Psychosom Med. 1979 May;41(3):209-18 [472086.001]
  • [Cites] Health Psychol. 1984;3(6):535-51 [6536502.001]
  • [Cites] J Consult Clin Psychol. 1986 Oct;54(5):616-22 [3771879.001]
  • [Cites] Cancer. 1987 Jan 1;59(1):189-96 [3491668.001]
  • [Cites] J Pers Soc Psychol. 1986 Dec;51(6):1173-82 [3806354.001]
  • [Cites] Women Health. 1986 Fall-Winter;11(3-4):101-30 [3564494.001]
  • [Cites] J Psychosom Res. 1987;31(3):311-6 [3625583.001]
  • [Cites] Brain Behav Immun. 1988 Mar;2(1):67-78 [3052653.001]
  • [Cites] Clin Immunol Immunopathol. 1989 Oct;53(1):1-23 [2670363.001]
  • [Cites] Psychosom Med. 1990 Jan-Feb;52(1):73-85 [2305024.001]
  • [Cites] Cancer. 1991 Feb 15;67(4):1097-117 [1991258.001]
  • [Cites] Cancer Res. 1992 Jan 15;52(2):456-63 [1345813.001]
  • [Cites] Cancer. 1993 Jan 1;71(1):231-6 [8416721.001]
  • [Cites] Health Psychol. 1993 Jan;12(1):16-23 [8462494.001]
  • [Cites] Psychol Bull. 1993 May;113(3):472-86 [8316610.001]
  • [Cites] Cancer. 1993 Jul 15;72(2):491-501 [8319179.001]
  • [Cites] Neoplasma. 1993;40(2):81-5 [8350959.001]
  • [Cites] J Pers Soc Psychol. 1993 Aug;65(2):375-90 [8366426.001]
  • [Cites] N Engl J Med. 1993 Oct 21;329(17):1246-53 [8105378.001]
  • [Cites] Psychosom Med. 1993 Jul-Aug;55(4):364-79 [8416086.001]
  • [Cites] Am Psychol. 1994 May;49(5):389-404 [8024167.001]
  • [Cites] J Cancer Res Clin Oncol. 1995;121(3):181-8 [7713990.001]
  • [Cites] Health Psychol. 1995 Mar;14(2):101-8 [7789344.001]
  • [Cites] Immunol Today. 1995 Jul;16(7):318-22 [7576063.001]
  • [Cites] Cell Immunol. 1996 May 25;170(1):71-7 [8660801.001]
  • [Cites] Clin Exp Immunol. 1996 Aug;105(2):344-52 [8706344.001]
  • [Cites] Annu Rev Psychol. 1997;48:411-47 [9046565.001]
  • [Cites] Psychosom Med. 1997 May-Jun;59(3):280-93 [9178339.001]
  • (PMID = 18835434.001).
  • [ISSN] 1090-2139
  • [Journal-full-title] Brain, behavior, and immunity
  • [ISO-abbreviation] Brain Behav. Immun.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA064710-09; United States / NCI NIH HHS / CA / R01 CA064710; United States / NCI NIH HHS / CA / R01 CA064710-09; United States / NCI NIH HHS / CA / R01-CA-064710
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Cytokines; WI4X0X7BPJ / Hydrocortisone
  • [Other-IDs] NLM/ NIHMS126658; NLM/ PMC2722111
  •  go-up   go-down


42. Coffin CM, Hornick JL, Fletcher CD: Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol; 2007 Apr;31(4):509-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The 59 IMTs had an age at diagnosis ranging from 3 weeks to 74 years (mean 13.2 y, median 11 y, 44% in the first decade).
  • Histologic evolution to a more pleomorphic cellular, spindled, polygonal, or round cell morphologic pattern was observed in 7 cases.
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / analysis. Child. Child, Preschool. Female. Humans. Immunohistochemistry. Infant. Infant, Newborn. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Prognosis. Receptor Protein-Tyrosine Kinases


43. Zieker D, Zieker J, Dietzsch J, Burnet M, Northoff H, Fehrenbach E: CDNA-microarray analysis as a research tool for expression profiling in human peripheral blood following exercise. Exerc Immunol Rev; 2005;11:86-96
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Changes have been shown in the cellular composition of peripheral blood and in gene expression within those cells.
  • These data suggest that gene expression fingerprints can serve as a powerful research tool to design novel strategies for diagnosis and treatment of exercise related injury and stress.
  • [MeSH-minor] Adult. Blood Chemical Analysis. Cluster Analysis. DNA Fingerprinting. Gene Expression Regulation. Humans. Male. Middle Aged. Running

  • MedlinePlus Health Information. consumer health - Exercise and Physical Fitness.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16385846.001).
  • [ISSN] 1077-5552
  • [Journal-full-title] Exercise immunology review
  • [ISO-abbreviation] Exerc Immunol Rev
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


44. Yin WH, Guo SP, Yang HY, Chan JK: Desmoplastic small round cell tumor of the submandibular gland--a rare but distinctive primary salivary gland neoplasm. Hum Pathol; 2010 Mar;41(3):438-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histologically, although there were irregular tumor islands lying in an abundant desmoplastic stroma, there were also areas comprising large cellular islands with scanty stroma in between, raising the differential diagnosis of various salivary gland carcinomas.
  • The diagnosis of desmoplastic small round cell tumor was confirmed by the presence of a polyphenotypic immunoprofile (positive for cytokeratin, desmin, and neuron-specific enolase) and the characteristic EWS-WT1 gene fusion.
  • Although rare, desmoplastic small round cell tumor has to be considered in the differential diagnosis of poorly differentiated neoplasms of the salivary gland, especially in young patients.
  • [MeSH-minor] Cell Proliferation. Combined Modality Therapy. Desmin / metabolism. Disease-Free Survival. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Keratins / metabolism. Male. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Treatment Outcome. Tumor Suppressor Protein p53 / metabolism. Young Adult

  • Genetic Alliance. consumer health - Desmoplastic Small Round Cell Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • [CommentIn] Hum Pathol. 2010 Apr;41(4):616-7; author reply 617 [20226963.001]
  • (PMID = 19913282.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Desmin; 0 / RNA, Messenger; 0 / Tumor Suppressor Protein p53; 68238-35-7 / Keratins
  •  go-up   go-down


45. Michal M, Hes O, Kazakov DV: Mesothelial glandular structures within pseudosarcomatous proliferative funiculitis--a diagnostic pitfall: report of 17 cases. Int J Surg Pathol; 2008 Jan;16(1):48-56
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The areas adjacent to the necrotic tissue comprised a cellular spindle cell proliferation with a haphazard arrangement of the myofibroblasts that in many areas revealed transitions into plump oval epithelioid cells and into cells with genuine epithelial appearances arranged in linear cords and often luminized into small microcysts.
  • All cellular elements were strongly positive with AE1/AE3 antibody.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Epithelium / pathology. Humans. Immunohistochemistry. Inflammation / metabolism. Inflammation / pathology. Male. Middle Aged. Testicular Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Testicular Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18203784.001).
  • [ISSN] 1066-8969
  • [Journal-full-title] International journal of surgical pathology
  • [ISO-abbreviation] Int. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Kong L, Yao SK, Liu JX, Wang N: [The prognostic value of cellular immunity function in patients with hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi; 2005 Mar;13(3):194-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The prognostic value of cellular immunity function in patients with hepatocellular carcinoma].
  • OBJECTIVES: To study the changes of cellular immunity function in patients with hepatocellular carcinoma (HCC) and its correlation with disease severity.
  • CONCLUSIONS: HCC patients have a cellular immunity dysfunction.
  • Measurement of these factors would be useful for early diagnosis and evaluating the prognoses of these patients.
  • [MeSH-minor] Adult. Antigens, CD28 / immunology. CD4-CD8 Ratio. CD8-Positive T-Lymphocytes / immunology. Female. Humans. Immunity, Cellular / immunology. Male. Middle Aged. Prognosis

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15760554.001).
  • [ISSN] 1007-3418
  • [Journal-full-title] Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
  • [ISO-abbreviation] Zhonghua Gan Zang Bing Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD28
  •  go-up   go-down


47. Ajit D, Gavas S, Jagtap S, Chinoy RF: Cytodiagnostic problems in cervicovaginal smears from symptomatic breast cancer patients on tamoxifen therapy. Acta Cytol; 2009 Jul-Aug;53(4):383-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tamoxifen-associated cellular changes can mimic morphologic features of cancer.
  • [MeSH-minor] Adenocarcinoma / pathology. Adult. Aged. Antineoplastic Agents, Hormonal / adverse effects. Breast Neoplasms / drug therapy. Diagnosis, Differential. False Positive Reactions. Female. Humans. Middle Aged


48. Wakely Jr PE, Bos GD, Mayerson J: The cytopathology of soft tissue mxyomas: ganglia, juxta-articular myxoid lesions, and intramuscular myxoma. Am J Clin Pathol; 2005 Jun;123(6):858-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We studied the practicality of issuing a cytologic diagnosis of myxoma/juxta-articular myxoid lesion/ganglion (MJG) by reviewing all fine-needle aspiration (FNA) biopsy specimens of soft tissue masses in our files with diagnoses of myxoma, myxoid cyst, myxoid lesion, ganglion, or ganglion cyst.
  • Of 39 cases with a cytologic diagnosis of soft tissue MJG, 15 had subsequent tissue biopsy or complete resection of the mass; 24 had clinicoradiologic follow-up.
  • Control group aspirates always contained cellular components that allowed distinction from MJGs.
  • The cytopathologic diagnosis of MJG lesions is accurate; FNA biopsy can be used to subtype MJGs into 3 categories when clinicoradiologic features are known.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biopsy, Fine-Needle. Female. Humans. Male. Middle Aged. Retrospective Studies

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15899776.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Chavan D, Ahmad F, Iyer P, Dalvi R, Kulkarni A, Mandava S, Das BR: Cytogenetic investigation in chronic myeloid leukemia: study from an Indian population. Asian Pac J Cancer Prev; 2006 Jul-Sep;7(3):423-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytogenetic investigation in chronic myeloid leukemia: study from an Indian population.
  • Chronic myeloid leukemia (CML) is a malignant neoplasm of hematopoietic cells characterized by abnormal proliferation of myeloid precursors, decreased rates of self destruction and an arrest in cellular differentiation.
  • It is the most common type of leukemia seen in India, accounting for 30% of all leukemias.
  • Cytogenetic analysis plays a vital and important role in the diagnosis of CML patients.
  • Furthermore, we believe that availability of more advanced molecular techniques can be used as a supportive tool in CML diagnosis even though it cannot fully replace cytogenetics, which remains the backbone for laboratory investigation of the disease.
  • [MeSH-major] Chromosome Aberrations. Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics. Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Bone Marrow / pathology. Child. Female. Humans. India. Karyotyping. Male. Middle Aged. Philadelphia Chromosome. Translocation, Genetic


50. de Vries B, Freilinger T, Vanmolkot KR, Koenderink JB, Stam AH, Terwindt GM, Babini E, van den Boogerd EH, van den Heuvel JJ, Frants RR, Haan J, Pusch M, van den Maagdenberg AM, Ferrari MD, Dichgans M: Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology; 2007 Dec 04;69(23):2170-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It will also facilitate the often difficult differential diagnosis from other causes of transient hemiparesis.
  • All six mutations caused functional changes in cellular assays.
  • [MeSH-minor] Adolescent. Adult. Age of Onset. Child. Child, Preschool. Codon, Nonsense. Genetic Testing. Germany. Humans. Mutation, Missense. NAV1.1 Voltage-Gated Sodium Channel. Netherlands. United States


51. Kaur G, Manucha V, Verma K: Gastrointestinal stromal tumors: Cytomorphologic spectrum in fine needle aspiration smears. Indian J Pathol Microbiol; 2010 Apr-Jun;53(2):271-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were four classical cases of gastrointestinal stromal tumors that showed tight cellular bundles and fascicles of slender spindle cells with scant cytoplasm.
  • CONCLUSION: The variability in cytologic features in GIST implies that a diagnosis of gastrointestinal stromal tumor should be rendered on cytology only in conjunction with immune-cytochemistry result of CD117.
  • [MeSH-major] Biopsy, Fine-Needle. Gastrointestinal Stromal Tumors / diagnosis. Gastrointestinal Stromal Tumors / pathology
  • [MeSH-minor] Adult. Aged. Cytological Techniques. Female. Humans. Immunohistochemistry. Male. Microscopy. Middle Aged

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20551531.001).
  • [ISSN] 0974-5130
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


52. Takeuchi M, Matsuzaki K, Nishitani H: Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. J Comput Assist Tomogr; 2010 Mar-Apr;34(2):173-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A relatively low ADC (1.08-1.20) in the 3 thecomas may reflect their abundant cellular nature, and the presence of low intensity on T2-weighted images was suggestive for benign fibrous tumor.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Feasibility Studies. Female. Humans. Middle Aged. Predictive Value of Tests. Retrospective Studies. Sensitivity and Specificity. Statistics, Nonparametric

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20351498.001).
  • [ISSN] 1532-3145
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


53. Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S: Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis. Transplantation; 2008 Jan 27;85(2):185-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis.
  • METHODS: We used an interferon-gamma enzyme-linked immunosorbent spot (ELISPOT) assay to measure the cellular immune response to peptides encoding BKV large T antigen.
  • Eight kidney transplant patients with BKVN were tested at the time of diagnosis of BKVN and then after resolution of active BKV infection.
  • RESULTS: When total spot counts from all peptide pools were combined, the mean ELISPOT signal per 10,000 cells at the time of BKVN diagnosis was 23.1 (range 3.4-59.7), with a median of 21.8.
  • The mean number of pools fitting this criteria at the time of BKVN diagnosis was 2.1 (range 0-8) with a median of 1.5; this increased to 8 (range 1-18) and a median of 6.5 after recovery (P=0.0338).
  • CONCLUSION: This demonstrates that recovery of cellular immune response to large T antigen corresponds with resolution of active BKV infection.
  • This may prove useful in monitoring patients' cellular immunity and recovery from active BKV infection when treated with reduction in immunosuppressive therapy.
  • [MeSH-major] Antigens, Polyomavirus Transforming / immunology. BK Virus / immunology. Immunity, Cellular. Kidney Transplantation / adverse effects. Kidney Transplantation / immunology. Nephritis / immunology. Polyomavirus Infections / immunology. Tumor Virus Infections / immunology
  • [MeSH-minor] Adult. Drug Therapy, Combination. Female. Humans. Immunosuppressive Agents / therapeutic use. Male. Middle Aged. Postoperative Complications / immunology. Postoperative Complications / virology. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Kidney Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18212622.001).
  • [ISSN] 0041-1337
  • [Journal-full-title] Transplantation
  • [ISO-abbreviation] Transplantation
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / T32 HL007209
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Polyomavirus Transforming; 0 / Immunosuppressive Agents
  •  go-up   go-down


54. Tse GM, Tan PH, Lacambra MD, Jara-Lazaro AR, Chan SK, Lui PC, Ma TK, Vong JS, Ng DC, Shi HJ, Lam WW: Papillary lesions of the breast--accuracy of core biopsy. Histopathology; 2010 Mar;56(4):481-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A benign core biopsy specimen diagnosis gave a false-negative rate of 10%, and malignant core biopsy specimen diagnosis did not give any false-positive results.
  • Using homogeneous ER (epithelial), positive CK14 (epithelial) and p63 (myoepithelial) immunoreactivity as benign criteria, the discordant rate was reduced by 30% and 69% when using all three or two of these three criteria for diagnosis.
  • CONCLUSIONS: Immunohistochemistry is helpful in core biopsy diagnosis of papillary breast lesions, but some cases remained misdiagnosed.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnostic Errors / statistics & numerical data. False Negative Reactions. False Positive Reactions. Female. Humans. Immunohistochemistry. Keratin-14 / analysis. Membrane Proteins / analysis. Middle Aged. Receptors, Estrogen / analysis. Retrospective Studies. Sensitivity and Specificity

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20459555.001).
  • [ISSN] 1365-2559
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CKAP4 protein, human; 0 / Keratin-14; 0 / Membrane Proteins; 0 / Receptors, Estrogen
  •  go-up   go-down


55. Fernandez-Flores A: Cutaneous leiomyomas and leiomyosarcomas: an immunohistochemical study with p53. Rom J Morphol Embryol; 2010;51(2):295-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Cutaneous smooth muscle tumors are rare and sometimes the differential diagnosis between leiomyoma and leiomyo-sarcoma is difficult and based in very subtle criteria.
  • All cases were reviewed in order to confirm the diagnosis, before the cases were included in the study.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Angiomyoma / metabolism. Angiomyoma / pathology. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20495746.001).
  • [ISSN] 1220-0522
  • [Journal-full-title] Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
  • [ISO-abbreviation] Rom J Morphol Embryol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Romania
  • [Chemical-registry-number] 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


56. Jakowski JD, Wakely PE Jr: Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases. Cancer; 2007 Oct 25;111(5):298-305
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purpose was to evaluate the cytomorphology of 8 EMC cases as obtained by imprint/scrape cytology and fine-needle aspiration (FNA) biopsy, to review the literature, and to demonstrate the utility of cytogenetic analysis in the diagnosis of EMC.
  • All patients had subsequent tissue confirmation of the diagnosis of EMC.
  • Five individuals presented as new patients, and 2 had a prior diagnosis of EMC.
  • Cytologic features ranged from hypocellular to highly cellular smears composed primarily of rounded cells set in an abundant myxoid stroma that varied from opaque to semitransparent and lacked vascularity or necrosis.
  • CONCLUSIONS: A confident cytologic diagnosis of EMC depends on the presence of a uniform, round to oval cell population often arranged in cords and set in an abundant myxoid/chondromyxoid background and arising in the appropriate clinical context.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cytodiagnosis. Female. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17676582.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. Wong NL, DI F: [Fine needle aspiration cytology of myxoid lesions of soft tissues: a study of 24 cases]. Zhonghua Bing Li Xue Za Zhi; 2007 Sep;36(9):619-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Ganglion, myxoma, and myxoid nodular fasciitis were the most common benign myxoid lesions of the soft tissues, all of which had low cellularity and lack of marked cellular atypia in smears in common.
  • Cytologically, they had high cellularity and various degrees of cellular atypia.
  • The coordinate rate to the histopathology diagnosis of the common myxoid lesions of the soft tissues was above 75% (benign 71.4% and malignancy 80% respectively).
  • [MeSH-minor] Adolescent. Adult. Aged. Bone Neoplasms / pathology. Bone Neoplasms / surgery. Chondrosarcoma / pathology. Chondrosarcoma / surgery. Diagnosis, Differential. Fasciitis / pathology. Fasciitis / surgery. Female. Humans. Male. Middle Aged. Myxoma / pathology. Myxoma / surgery. Prognosis. Sarcoma / pathology. Sarcoma / surgery. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18070452.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


58. Taniyama K, Motoshita J, Sakane J, Makita K, Akai Y, Daito M, Otomo Y, Ono H, Mizunoe T, Takeuchi Y, Tominaga H, Koseki M: Combination analysis of a whole lymph node by one-step nucleic acid amplification and histology for intraoperative detection of micrometastasis. Pathobiology; 2006;73(4):183-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Then, 91 LN submitted for HE from 6 patients with advanced colorectal adenocarcinoma and 64 LN submitted for frozen diagnosis from 47 patients with different malignancies were examined by OSNA and HE.
  • Carcinoma metastasis showing either HE+ or OSNA+ was detected in 7.9% of the LN from advanced colorectal adenocarcinomas and in 30.0% of the LN for frozen diagnosis from different malignancies; HE-/OSNA+ metastasis was detected in 4.8 and 4.0%, respectively.
  • [MeSH-major] Adenocarcinoma / diagnosis. Colorectal Neoplasms / diagnosis. Lymph Node Excision / methods. Lymph Nodes / pathology. Lymphatic Metastasis / diagnosis. Nucleic Acid Amplification Techniques
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Colon / pathology. Female. Frozen Sections. Humans. Intraoperative Period. Keratin-19 / genetics. Keratin-19 / metabolism. Male. Middle Aged. RNA, Messenger / metabolism. RNA, Neoplasm / analysis. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17119347.001).
  • [ISSN] 1015-2008
  • [Journal-full-title] Pathobiology : journal of immunopathology, molecular and cellular biology
  • [ISO-abbreviation] Pathobiology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Keratin-19; 0 / RNA, Messenger; 0 / RNA, Neoplasm
  •  go-up   go-down


59. Kim HJ, Lee HK, Seo JJ, Kim HJ, Shin JH, Jeong AK, Lee JH, Cho KJ: MR imaging of solitary fibrous tumors in the head and neck. Korean J Radiol; 2005 Jul-Sep;6(3):136-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An exceptional case of pituitary SFT was hypointense on the T2-weighted images and it was hyperdense on the unenhanced CT images, which correlated with the increased collagenous component and the cellular compactness.
  • CONCLUSION: The imaging features of SFT are nonspecific; however, SFT should be included in the differential diagnosis of masses involving the intracranial and extracranial head and neck regions.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Magnetic Resonance Imaging. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Retrospective Studies. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1991 Dec;19(6):515-22 [1786936.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1998;255(1):18-21 [9592669.001]
  • [Cites] Ann Thorac Surg. 2005 Jan;79(1):303-7 [15620963.001]
  • [Cites] Am J Surg Pathol. 1989 Aug;13(8):640-58 [2665534.001]
  • [Cites] Histopathology. 1986 Aug;10(8):867-75 [2428726.001]
  • [Cites] J Comput Assist Tomogr. 2002 Mar-Apr;26(2):174-9 [11884769.001]
  • [Cites] J Neurooncol. 2001 Aug;54(1):57-69 [11763424.001]
  • [Cites] AJNR Am J Neuroradiol. 2001 Nov-Dec;22(10):1890-2 [11733322.001]
  • [Cites] Otolaryngol Head Neck Surg. 1999 Dec;121(6):826-8 [10580246.001]
  • [Cites] AJR Am J Roentgenol. 1992 May;158(5):983-6 [1566702.001]
  • [Cites] AJNR Am J Neuroradiol. 1996 Oct;17(9):1767-72 [8896635.001]
  • [Cites] J Comput Assist Tomogr. 1997 Jan-Feb;21(1):115-20 [9022782.001]
  • [Cites] Skeletal Radiol. 1990;19(7):495-9 [2255947.001]
  • [Cites] Ann Diagn Pathol. 2004 Oct;8(5):268-75 [15494932.001]
  • [Cites] AJNR Am J Neuroradiol. 2002 Mar;23(3):473-5 [11901021.001]
  • (PMID = 16145288.001).
  • [ISSN] 1229-6929
  • [Journal-full-title] Korean journal of radiology
  • [ISO-abbreviation] Korean J Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2685036
  •  go-up   go-down


60. Quintana LF, Campistol JM, Alcolea MP, Bañon-Maneus E, Sol-González A, Cutillas PR: Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics; 2009 Jul;8(7):1658-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These peptides are therefore potential biomarkers that might be used for the diagnosis of CAD.
  • [MeSH-major] Biomarkers / urine. Kidney Transplantation. Peptides. Primary Graft Dysfunction / diagnosis. Primary Graft Dysfunction / urine. Proteomics / methods. Transplantation, Homologous
  • [MeSH-minor] Adult. Aged. Amino Acid Sequence. Chromatography, Liquid / methods. Cluster Analysis. Female. Humans. Kidney / chemistry. Kidney / metabolism. Male. Middle Aged. Molecular Sequence Data. Phenotype. Reproducibility of Results. Tandem Mass Spectrometry / methods

  • MedlinePlus Health Information. consumer health - Kidney Transplantation.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 1999 Dec 2;341(23):1725-30 [10580071.001]
  • [Cites] Nephron. 2000 Jun;85(2):97-102 [10867513.001]
  • [Cites] Nat Biotechnol. 2001 Mar;19(3):242-7 [11231557.001]
  • [Cites] J Am Soc Nephrol. 2001 Apr;12(4):822-7 [11274244.001]
  • [Cites] J Am Soc Nephrol. 2001 Oct;12(10):2108-16 [11562409.001]
  • [Cites] Proteomics. 2001 Jan;1(1):93-107 [11680902.001]
  • [Cites] Anal Chem. 2001 Dec 1;73(23):5635-44 [11774901.001]
  • [Cites] Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266 [11904577.001]
  • [Cites] Clin Sci (Lond). 2003 May;104(5):483-90 [12529166.001]
  • [Cites] Contrib Nephrol. 2004;141:155-69 [14650231.001]
  • [Cites] Am J Kidney Dis. 2003 Dec;42(6 Suppl 5):A5-7, S1-230 [14655179.001]
  • [Cites] N Engl J Med. 2003 Dec 11;349(24):2326-33 [14668458.001]
  • [Cites] Transplantation. 2004 Sep 15;78(5):719-24 [15371675.001]
  • [Cites] Kidney Int. 1979 Sep;16(3):279-89 [393892.001]
  • [Cites] J Pathol. 1983 Feb;139(2):193-206 [6338185.001]
  • [Cites] Clin Chem. 1993 Apr;39(4):561-77 [8472349.001]
  • [Cites] Br J Urol. 1994 Jan;73(1):13-5 [8298893.001]
  • [Cites] Urol Res. 1994;22(3):131-6 [7992456.001]
  • [Cites] Kidney Int. 1996 Jul;50(1):235-42 [8807593.001]
  • [Cites] Scand J Urol Nephrol. 1997 Dec;31(6):555-9 [9458515.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8 [9843981.001]
  • [Cites] Curr Opin Nephrol Hypertens. 1998 Nov;7(6):691-4 [9864667.001]
  • [Cites] Kidney Int. 1999 Feb;55(2):713-23 [9987096.001]
  • [Cites] J Am Soc Mass Spectrom. 1999 Jul;10(7):625-34 [10384726.001]
  • [Cites] Kidney Int. 1999 Sep;56(3):783-93 [10469349.001]
  • [Cites] Mol Cell Proteomics. 2005 Aug;4(8):1038-51 [15879432.001]
  • [Cites] Am J Transplant. 2005 Oct;5(10):2464-72 [16162196.001]
  • [Cites] Mol Cell Proteomics. 2006 Jan;5(1):144-56 [16219938.001]
  • [Cites] Nat Chem Biol. 2005 Oct;1(5):252-62 [16408053.001]
  • [Cites] Transplantation. 2006 Mar 15;81(5):643-54 [16534463.001]
  • [Cites] Mol Biosyst. 2006 May;2(5):221-30 [16880940.001]
  • [Cites] Nat Biotechnol. 2006 Aug;24(8):971-83 [16900146.001]
  • [Cites] Mol Cell Proteomics. 2006 Oct;5(10):1727-44 [16887931.001]
  • [Cites] J Mass Spectrom. 2006 Nov;41(11):1399-413 [17051522.001]
  • [Cites] Genome Biol. 2006;7(9):R80 [16948836.001]
  • [Cites] Transplantation. 2007 Feb 27;83(4):448-57 [17318078.001]
  • [Cites] Clin Chem. 2007 Mar;53(3):375-6 [17327502.001]
  • [Cites] Am J Transplant. 2007 Mar;7(3):518-26 [17352710.001]
  • [Cites] Nat Clin Pract Nephrol. 2007 Apr;3(4):208-21 [17389890.001]
  • [Cites] Transpl Int. 2007 Jul;20(7):608-15 [17521383.001]
  • [Cites] Cell. 2007 Aug 10;130(3):395-8 [17693247.001]
  • [Cites] Mol Cell Proteomics. 2007 Aug;6(8):1291-8 [17513294.001]
  • [Cites] Mol Cell Proteomics. 2007 Sep;6(9):1560-73 [17565973.001]
  • [Cites] Clin J Am Soc Nephrol. 2008 Jan;3 Suppl 1:S3-10 [18178794.001]
  • [Cites] J Proteome Res. 2008 Apr;7(4):1615-28 [18290607.001]
  • [Cites] Kidney Int. 2008 May;73(10):1114-9 [18272958.001]
  • [Cites] Kidney Int. 2008 Jun;73(11):1216-9 [18322541.001]
  • [Cites] J Am Soc Nephrol. 2009 Feb;20(2):428-35 [19056874.001]
  • (PMID = 19357086.001).
  • [ISSN] 1535-9484
  • [Journal-full-title] Molecular & cellular proteomics : MCP
  • [ISO-abbreviation] Mol. Cell Proteomics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Peptides
  • [Other-IDs] NLM/ PMC2709192
  •  go-up   go-down


61. Herwig MC, Vogel A, Holz FG, Löffler KU: [Pilomatrixoma of the ocular adnexae: clinical and histologic analysis (13 cases)]. Klin Monbl Augenheilkd; 2009 May;226(5):404-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 3 cases the correct diagnosis was made intraoperatively, while no pilomatrixoma was diagnosed prior to surgery.
  • Immunhistochemical staining with anti-Ki67 and anti-CAS/CSE1L indicated a regular cellular maturation of the basophilic cells.
  • While it is usually not recognised clinically, it should be considered in the differential diagnosis especially for tumours of the upper eyelid.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Humans. Male. Middle Aged. Young Adult

  • Genetic Alliance. consumer health - Pilomatrixoma.
  • MedlinePlus Health Information. consumer health - Hair Problems.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19399712.001).
  • [ISSN] 1439-3999
  • [Journal-full-title] Klinische Monatsblätter für Augenheilkunde
  • [ISO-abbreviation] Klin Monbl Augenheilkd
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


62. Catapano G, Patzer JF 2nd, Gerlach JC: Transport advances in disposable bioreactors for liver tissue engineering. Adv Biochem Eng Biotechnol; 2009;115:117-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Acute liver failure (ALF) is a devastating diagnosis with an overall survival of approximately 60%.
  • In fact, adult hepatocytes perform all essential liver functions.
  • Ambiguous clinical results, the time loss of cellular activity during treatment, and the presence of a necrotic core in the cell compartment of many bioreactors suggest that improvement of transport of nutrients, and metabolic wastes and products to or from the cells in the bioreactor is critical for the development of therapeutically effective BALs.
  • [MeSH-major] Bioreactors. Cell Culture Techniques / instrumentation. Disposable Equipment. Hepatocytes / metabolism. Liver / metabolism. Liver Failure, Acute / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19499208.001).
  • [ISSN] 0724-6145
  • [Journal-full-title] Advances in biochemical engineering/biotechnology
  • [ISO-abbreviation] Adv. Biochem. Eng. Biotechnol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Membranes, Artificial
  •  go-up   go-down


63. Galic E, Krpan D, Mirat J, Kusec V: Diversity of bone cell activity as a histomorphometric feature of idiopathic osteoporosis in men. Aging Male; 2010 Mar;13(1):18-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cellular parameters and MAR indicated variations in bone cell actions.
  • Our results suggest that idiopathic osteoporosis in man resembles many characteristics of postmenopausal osteoporosis in women resulting in impaired trabecular structure due to unbalanced cellular activity and bone turnover rate.
  • [MeSH-minor] Adult. Aged. Bone Density. Female. Hip / pathology. Hip / radiography. Hip Fractures / pathology. Hip Fractures / radiography. Humans. Lumbar Vertebrae / pathology. Lumbar Vertebrae / radiography. Male. Middle Aged. Spinal Fractures / diagnosis. Spinal Fractures / pathology

  • Genetic Alliance. consumer health - Osteoporosis.
  • MedlinePlus Health Information. consumer health - Osteoporosis.
  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20148745.001).
  • [ISSN] 1473-0790
  • [Journal-full-title] The aging male : the official journal of the International Society for the Study of the Aging Male
  • [ISO-abbreviation] Aging Male
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


64. Daccarett M, Segerson NM, Günther J, Nölker G, Gutleben K, Brachmann J, Marrouche NF: Blinded correlation study of three-dimensional electro-anatomical image integration and phased array intra-cardiac echocardiography for left atrial mapping. Europace; 2007 Oct;9(10):923-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Atrial Fibrillation / diagnosis. Cardiology / methods. Female. Heart Atria / pathology. Humans. Imaging, Three-Dimensional. Male. Middle Aged. Models, Anatomic. Observer Variation. Prospective Studies. Reproducibility of Results

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17827162.001).
  • [ISSN] 1099-5129
  • [Journal-full-title] Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • [ISO-abbreviation] Europace
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


65. Kelly NP, Lim JC, DeJong S, Harmath C, Dudiak C, Wojcik EM: Specimen adequacy and diagnostic specificity of ultrasound-guided fine needle aspirations of nonpalpable thyroid nodules. Diagn Cytopathol; 2006 Mar;34(3):188-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All 19 cases met criteria for specimen adequacy, and in 17 cases (89%) specific cytologic diagnoses were made (cellular/adenomatous nodule--2 cases, colloid nodule--10 cases, Hashimoto's thyroiditis--4 cases, and papillary cystic carcinoma--1 case).
  • In one case, a diagnosis of lymphocytic thyroiditis versus intrathyroidal lymphoid tissue was made (See Table I).
  • In majority of cases of USG-FNA of nonpalpable thyroid nodules, adequate material may be obtained for a specific cytopathologic diagnosis.
  • [MeSH-major] Biopsy, Fine-Needle / methods. Specimen Handling. Thyroid Nodule / diagnosis. Thyroid Nodule / pathology
  • [MeSH-minor] Adult. Aged. Carcinoma, Papillary / diagnosis. Carcinoma, Papillary / pathology. Cytodiagnosis / methods. Female. Hashimoto Disease / diagnosis. Hashimoto Disease / pathology. Humans. Male. Middle Aged. Retrospective Studies. Sensitivity and Specificity. Thyroid Neoplasms / diagnosis. Thyroid Neoplasms / pathology. Ultrasonography / methods

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2006 Wiley-Liss, Inc.
  • (PMID = 16470862.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


66. Li XC, Shang JB, Wu XM, Zeng QS, Sun CP, He JX, Zhong ZW, Chen ZS: [MRI findings of uterine cervical cancer and value of MRI in preoperative staging]. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar;27(3):352-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To evaluate the value of magnetic resonance imaging (MRI) in diagnosis and preoperative staging of uterine cervical cancer.
  • CONCLUSION: MRI can accurately describe the size and invasion of uterine cervical cancer, especially useful in detecting parametrial invasion, but for diagnosis of IA uterine cervical cancer, MRI findings are not sufficient without considerations of clinical findings and cellular examination.
  • [MeSH-minor] Adult. Aged. Female. Humans. Middle Aged. Neoplasm Invasiveness. Preoperative Care. Reproducibility of Results


67. Ward SC, Thung SN, Lim KH, Tran TT, Hong TK, Hoang PL, Jang JJ, Park YN, Abe K: Hepatic progenitor cells in liver cancers from Asian children. Liver Int; 2010 Jan;30(1):102-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: There was agreement on the diagnosis of 24 cases of HCC and 10 cases of HB (one recurrent case).
  • The diagnosis was split for six cases (HCC/HB).
  • Paediatric HCC has a morphology different from adult HCC, sometimes resembling HB, and a larger proportion of paediatric tumours have progenitor cell features.
  • CONCLUSIONS: HB and HCC in children may represent malignant transformation at an early stage in the cellular lineage and often arise from hepatic progenitor cells.

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stem Cells.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19793197.001).
  • [ISSN] 1478-3231
  • [Journal-full-title] Liver international : official journal of the International Association for the Study of the Liver
  • [ISO-abbreviation] Liver Int.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Cell Adhesion Molecules; 0 / DNA, Viral; 0 / Keratin-19; 0 / RNA, Viral; 0 / tumor-associated antigen GA733; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


68. Sapino A, Bosco M, Cassoni P, Castellano I, Arisio R, Cserni G, Dei Tos AP, Fortunati N, Catalano MG, Bussolati G: Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol; 2006 Apr;19(4):599-606
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The highest percentage of ER-beta was observed in fibroadenomas with cellular stroma and in phyllodes tumors.
  • In addition, the mean age at diagnosis was significantly lower in patients with ER-beta-positive vs ER-beta-negative fibroadenomas.
  • [MeSH-minor] Actins / analysis. Adolescent. Adult. Aged. Calcium-Binding Proteins / analysis. Cell Line, Tumor. Estrogen Receptor alpha / analysis. Estrogen Receptor alpha / genetics. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. Microfilament Proteins / analysis. Middle Aged. Muscle, Smooth / chemistry. RNA, Messenger / genetics. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16554735.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Calcium-Binding Proteins; 0 / Estrogen Receptor alpha; 0 / Estrogen Receptor beta; 0 / Microfilament Proteins; 0 / RNA, Messenger; 0 / calponin
  •  go-up   go-down


69. Hantschke M, Mentzel T, Rütten A, Palmedo G, Calonje E, Lazar AJ, Kutzner H: Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am J Surg Pathol; 2010 Feb;34(2):216-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The dense cellular aggregates were encased by delicate fibrous septa.


70. Nassar H, Qureshi H, Adsay NV, Visscher D: Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol; 2006 Apr;30(4):501-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Solid papillary carcinomas (SPCs) are uncommon tumors composed of circumscribed large cellular nodules separated by bands of dense fibrosis.
  • Overall, 11.7% died of their tumor, 1 to 4 years after diagnosis (mean, 2.3 years); none of them belongs to the group of noninvasive SPC.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor. Combined Modality Therapy. Disease-Free Survival. Female. Follow-Up Studies. Humans. Lymph Node Excision. Male. Middle Aged. Mucins / metabolism. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Am J Surg Pathol. 2011 Dec;35(12):1908. Volkanadsay, N [corrected to Adsay, N Volkan]
  • (PMID = 16625097.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Mucins
  •  go-up   go-down


71. Cantù Rajnoldi A, Fenu S, Kerndrup G, van Wering ER, Niemeyer CM, Baumann I, European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS): Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Ann Hematol; 2005 Jul;84(7):429-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Accurately defined and restrictively applied cellular features of dysplasia are an important tool to improve and ensure the concordance in the diagnosis of MDS among investigators.
  • [MeSH-minor] Adult. Child. Child, Preschool. Evaluation Studies as Topic. Female. Humans. Male


72. Parovichnikova EN, Gal'tseva IV, Vorob'ev IA, Savchenko VG: [Characteristics of T-cell immunity in patients with acute leukemia]. Ter Arkh; 2006;78(7):18-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Characteristics of T-cell immunity in patients with acute leukemia].
  • AIM: To study a cytokine profile of cytotoxic T-cells and T-helpers at diagnosis of acute myeloid and lymphoblastic leukemia (AML and ALL) and at different stages of its treatment.
  • MATERIAL AND METHODS: T-cell population of peripheral blood lymphocytes was studied in 19 AML patients at diagnosis, 13 AML patients in remission, 5 AML patients in developing recurrence and 5 ALL patients at diagnosis.
  • The percentage of CD3+CD8- cells (T-helpers) producing IF-g was similar in the patients at diagnosis and in complete remission being higher than in healthy donors.
  • CONCLUSION: The results obtained evidence for different polarization of T-cell immunity in AML and ALL patients at the time of diagnosis, remission and recurrence: in the onset of AML there was an increase in the production of Th1--proinflammatory cytokines, in ALL--in percent of Th-2 cytokines.
  • [MeSH-major] Leukemia / immunology. T-Lymphocytes / immunology
  • [MeSH-minor] Acute Disease. Adolescent. Adult. Antigens, CD / biosynthesis. Antigens, CD / immunology. Cytokines / biosynthesis. Cytokines / immunology. Female. Flow Cytometry. Humans. Immunity, Cellular. Male. Middle Aged. Th1 Cells / immunology. Th1 Cells / metabolism. Th2 Cells / immunology. Th2 Cells / metabolism

  • MedlinePlus Health Information. consumer health - Childhood Leukemia.
  • MedlinePlus Health Information. consumer health - Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16944746.001).
  • [ISSN] 0040-3660
  • [Journal-full-title] Terapevticheskiĭ arkhiv
  • [ISO-abbreviation] Ter. Arkh.
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Cytokines
  •  go-up   go-down


73. Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, Hoh R, Stramer SL, Linnen JM, McCune JM, Martin JN, Busch MP, Deeks SG: Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol; 2009 Jan;83(1):329-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The median duration of HIV diagnosis was 13 years, the median baseline CD4(+) T-cell count was 753 cells/mm(3), and the median duration of follow-up was 16 months.
  • Plasma and cellular HIV RNA levels were measured using the transcription-mediated amplification (TMA) assay (estimated limit of detection of <3.5 copies RNA/ml).

  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6776-81 [17428922.001]
  • [Cites] AIDS. 2000 Jan 28;14(2):123-31 [10708282.001]
  • [Cites] PLoS Pathog. 2007 Apr;3(4):e46 [17411338.001]
  • [Cites] Nat Genet. 2007 Jun;39(6):733-40 [17496894.001]
  • [Cites] Science. 2007 Aug 17;317(5840):944-7 [17641165.001]
  • [Cites] Immunity. 2007 Sep;27(3):406-16 [17892849.001]
  • [Cites] N Engl J Med. 2007 Nov 8;357(19):1903-15 [17989383.001]
  • [Cites] Nat Immunol. 2007 Dec;8(12):1324-36 [17952079.001]
  • [Cites] J Infect Dis. 2008 Jan 1;197(1):126-33 [18171295.001]
  • [Cites] J Infect Dis. 2008 Feb 15;197(4):563-71 [18275276.001]
  • [Cites] AIDS. 1997 Dec;11(15):1833-8 [9412701.001]
  • [Cites] J Virol. 2008 Sep;82(17):8422-30 [18562530.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14 [10694578.001]
  • [Cites] J Virol. 2000 May;74(9):4361-76 [10756051.001]
  • [Cites] Virology. 2000 Oct 10;276(1):169-80 [11022005.001]
  • [Cites] Transfusion. 2002 May;42(5):527-36 [12084160.001]
  • [Cites] Nat Immunol. 2002 Nov;3(11):1061-8 [12368910.001]
  • [Cites] J Immunol. 2002 Dec 1;169(11):6376-85 [12444145.001]
  • [Cites] J Virol. 2003 Jun;77(11):6108-16 [12743268.001]
  • [Cites] J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):625-34 [12902808.001]
  • [Cites] AIDS. 2003 Sep 5;17(13):1871-9 [12960819.001]
  • [Cites] Blood. 2004 Feb 1;103(3):966-72 [12958069.001]
  • [Cites] N Engl J Med. 2004 Aug 19;351(8):760-8 [15317889.001]
  • [Cites] AIDS. 1991 Oct;5(10):1201-7 [1786148.001]
  • [Cites] N Engl J Med. 1995 Jan 26;332(4):228-32 [7808489.001]
  • [Cites] J Virol. 1995 Jul;69(7):4228-36 [7769682.001]
  • [Cites] J Virol. 1995 Sep;69(9):5743-53 [7637019.001]
  • [Cites] Science. 1995 Nov 10;270(5238):988-91 [7481804.001]
  • [Cites] Transfusion. 1996 Jan;36(1):45-52 [8607152.001]
  • [Cites] Science. 1996 Sep 27;273(5283):1856-62 [8791590.001]
  • [Cites] Virology. 1996 Sep 1;223(1):224-32 [8806556.001]
  • [Cites] J Virol. 1997 Jul;71(7):5608-13 [9188635.001]
  • [Cites] AIDS. 1997 Sep;11(11):F73-8 [9302436.001]
  • [Cites] JAMA. 1998 Jul 1;280(1):42-8 [9660362.001]
  • [Cites] JAMA. 1998 Sep 23-30;280(12):1080-5 [9757856.001]
  • [Cites] J Infect Dis. 1999 Aug;180(2):526-9 [10395875.001]
  • [Cites] J Infect Dis. 2005 Feb 1;191(3):348-57 [15633093.001]
  • [Cites] Science. 2005 Mar 4;307(5714):1434-40 [15637236.001]
  • [Cites] J Virol. 2005 May;79(10):6551-3 [15858041.001]
  • [Cites] AIDS. 2005 Aug 12;19(12):1323-5 [16052089.001]
  • [Cites] Transfusion. 2005 Aug;45(8):1280-90 [16078913.001]
  • [Cites] Clin Infect Dis. 2005 Oct 1;41(7):1053-6 [16142675.001]
  • [Cites] J Virol. 2005 Nov;79(22):14169-78 [16254352.001]
  • [Cites] Transfusion. 2005 Dec;45(12):1853-63 [16371038.001]
  • [Cites] Clin Infect Dis. 2006 Mar 1;42(5):700-8 [16447118.001]
  • [Cites] J Virol. 2006 May;80(10):5074-7 [16641299.001]
  • [Cites] Blood. 2006 Jun 15;107(12):4781-9 [16467198.001]
  • [Cites] Transfusion. 2006 Nov;46(11):1870-8 [17076840.001]
  • [Cites] J Virol. 2007 Mar;81(5):2508-18 [17151109.001]
  • [Cites] AIDS Patient Care STDS. 2007 Feb;21(2):100-5 [17328659.001]
  • [Cites] J Virol. 2007 Apr;81(7):3465-76 [17251286.001]
  • [Cites] Hepatology. 2008 May;47(5):1446-52 [18220272.001]
  • [Cites] Science. 2008 May 9;320(5877):760-4 [18467582.001]
  • [Cites] Clin Infect Dis. 2008 Jul 1;47(1):102-4 [18494606.001]
  • [Cites] AIDS. 2007 May 11;21(8):1043-5 [17457100.001]
  • (PMID = 18945778.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIMH NIH HHS / MH / P30 MH062246; United States / NIAID NIH HHS / AI / U01 AI067854; United States / NIAID NIH HHS / AI / R21 AI055273; United States / NCRR NIH HHS / RR / RR16482; United States / NIAID NIH HHS / AI / K23AI075985; United States / NCRR NIH HHS / RR / K24 RR016482; United States / NIAID NIH HHS / AI / R01 AI052745; United States / NIH HHS / OD / DP1 OD000329; United States / NIMH NIH HHS / MH / P30 MH59037; United States / NCRR NIH HHS / RR / 5-MO1-RR00083-37; United States / NIAID NIH HHS / AI / AI055273; United States / NIAID NIH HHS / AI / K23 AI075985; United States / NIAID NIH HHS / AI / P30 AI027763; United States / NIAID NIH HHS / AI / U01-AI067854; United States / NCRR NIH HHS / RR / M01 RR000083; United States / NIMH NIH HHS / MH / P30 MH62246; United States / NIAID NIH HHS / AI / P30 AI27763; United States / NIAID NIH HHS / AI / AI052745
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2612329
  •  go-up   go-down


74. Fabron A Jr, Lopes LB, Bordin JO: Transfusion-related acute lung injury. J Bras Pneumol; 2007 Mar-Apr;33(2):206-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transfusion-related acute lung injury.
  • Transfusion-related acute lung injury (TRALI) is a serious clinical syndrome associated with the transfusion of plasma-containing blood components.
  • Although the mechanism of TRALI has not been fully elucidated, it has been associated with human leukocyte antigen antibodies (class I, class II or neutrophil alloantigens) and with biologically active mediators in stored cellular blood components.
  • Rarely diagnosed, TRALI can be confused with other causes of acute respiratory failure.
  • [MeSH-major] Blood Transfusion / adverse effects. Respiratory Distress Syndrome, Adult / diagnosis
  • [MeSH-minor] Blood Donors. Diagnosis, Differential. Europe / epidemiology. Female. HLA Antigens / immunology. Humans. Male. North America / epidemiology. Risk Factors

  • MedlinePlus Health Information. consumer health - Blood Transfusion and Donation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17724541.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] eng; por
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / HLA Antigens
  • [Number-of-references] 17
  •  go-up   go-down


75. Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I, Gavish M, Nagler RM: Salivary analysis of oral cancer biomarkers. Br J Cancer; 2009 Oct 6;101(7):1194-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We tested 19 tongue cancer patients, measuring the levels of 8 salivary markers related to oxidative stress, DNA repair, carcinogenesis, metastasis and cellular proliferation and death.
  • Cancer-related changes in salivary tumour markers may be used as a diagnostic tool for diagnosis, prognosis and post-operative monitoring.
  • [MeSH-major] Biomarkers, Tumor / analysis. Saliva / chemistry. Tongue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / diagnosis. Cyclin D1 / analysis. DNA Glycosylases / analysis. Female. Humans. Ki-67 Antigen / analysis. Male. Matrix Metalloproteinase 9 / analysis. Middle Aged. Neoplasm Staging. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Oral cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Otolaryngol Head Neck Surg. 2000 Jan;122(1):44-51 [10629481.001]
  • [Cites] Oncol Rep. 2009 Apr;21(4):917-23 [19287989.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2000 Sep;126(9):1079-85 [10979120.001]
  • [Cites] J Investig Med. 2002 May;50(3):214-25 [12033287.001]
  • [Cites] Head Neck. 2003 Apr;25(4):280-8 [12658732.001]
  • [Cites] Otolaryngol Head Neck Surg. 2004 Oct;131(4):472-6 [15467620.001]
  • [Cites] Am J Surg. 1998 Mar;175(3):242-4 [9560130.001]
  • [Cites] EMBO J. 2005 Apr 6;24(7):1311-7 [15775985.001]
  • [Cites] Cells Tissues Organs. 2005;179(1-2):73-80 [15942195.001]
  • [Cites] Clin Lung Cancer. 2005 Sep;7 Suppl 1:S39-44 [16159418.001]
  • [Cites] Oral Oncol. 2006 Jul;42(6):625-31 [16483832.001]
  • [Cites] Clin Cancer Res. 2006 Jul 1;12(13):3979-84 [16818695.001]
  • [Cites] Adv Clin Chem. 2006;42:1-41 [17131623.001]
  • [Cites] Cancer Res. 2006 Dec 15;66(24):11683-9 [17178863.001]
  • [Cites] Cancer. 2007 Jan 1;109(1):54-9 [17099862.001]
  • [Cites] Oral Oncol. 2007 Jan;43(1):51-9 [16798062.001]
  • [Cites] Oral Oncol. 2007 Mar;43(3):272-7 [17174141.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2007 Apr;19(3):177-81 [17359903.001]
  • [Cites] Clin Neurol Neurosurg. 2007 Sep;109(7):561-6 [17555871.001]
  • [Cites] J Cancer Res Clin Oncol. 2007 Sep;133(9):613-7 [17479291.001]
  • [Cites] J Craniofac Surg. 2007 Sep;18(5):1039-43 [17912078.001]
  • [Cites] Eur J Surg Oncol. 2008 Apr;34(4):450-5 [17498910.001]
  • [Cites] Clin Cancer Res. 2008 Apr 15;14(8):2378-86 [18413828.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1034-42 [18483323.001]
  • [Cites] Cancer Lett. 2008 Jul 18;266(1):60-72 [18374480.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2008 Jul;265 Suppl 1:S97-104 [18236066.001]
  • [Cites] Clin Chem. 2008 Nov;54(11):1770-9 [18801934.001]
  • [Cites] Neoplasia. 2008 Dec;10(12):1393-401 [19048118.001]
  • [Cites] Semin Oncol. 2009 Feb;36(1):60-4 [19179189.001]
  • [Cites] Br J Cancer. 2000 Sep;83(5):614-9 [10944601.001]
  • (PMID = 19789535.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CCND1 protein, human; 0 / Ki-67 Antigen; 136601-57-5 / Cyclin D1; EC 3.2.2.- / DNA Glycosylases; EC 3.2.2.- / oxoguanine glycosylase 1, human; EC 3.4.24.35 / Matrix Metalloproteinase 9
  • [Other-IDs] NLM/ PMC2768098
  •  go-up   go-down


76. Hurlstone DP, Baraza W, Brown S, Thomson M, Tiffin N, Cross SS: In vivo real-time confocal laser scanning endomicroscopic colonoscopy for the detection and characterization of colorectal neoplasia. Br J Surg; 2008 May;95(5):636-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim was to assess prospectively the clinical applicability and predictive power of the EC3870CIFK confocal laser endomicroscope (CLE) for the in vivo diagnosis of intraepithelial neoplasia during colonoscopy.
  • METHODS: Lesions were identified using chromoscopy followed by CLE imaging and graded according to vascular and cellular changes.
  • CONCLUSION: Confocal laser endomicroscopy permits high-quality cellular, subsurface vascular and stromal imaging, enabling prediction of intraepithelial neoplasia with a high level of accuracy.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biopsy / methods. Female. Humans. Length of Stay. Male. Middle Aged. Observer Variation. Prospective Studies. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Colonoscopy.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
  • (PMID = 18324640.001).
  • [ISSN] 1365-2168
  • [Journal-full-title] The British journal of surgery
  • [ISO-abbreviation] Br J Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


77. Salamano R, Braselli A, Hoppe A, Monteghirfo R, Silva T: [Neurolisteriosis in adults: report of six clinical cases]. Arq Neuropsiquiatr; 2005 Dec;63(4):1063-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It affects newborn as well as elderly people, patients with deficiencies in their cellular immune systems, and healthy adults.
  • It presents most commonly as an acute meningitis, although it can present itself as cerebritis, brain stem encephalitis (rhomboencephalitis), and exceptionally as myelitis.
  • PATIENTS: We describe six clinical cases of neurolisterioris, five of which in healthy adults; we also describe the images and cerebrospinal fluid (CSF) findings, RESULTS: Three patients contracted acute meningitis, one of them meningoencephalitis, one cerebritis and the last one rhomboencephalitis.
  • The diagnosis was made in five through culture of CSF.
  • CONCLUSION: Neurolisteriosis has to be kept in mind as a feasible diagnosis not only in immunocompromised but also in newborn as well as elderly patients.
  • [MeSH-major] Central Nervous System Bacterial Infections / microbiology. Listeria monocytogenes / isolation & purification. Listeriosis / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Ampicillin / therapeutic use. Anti-Bacterial Agents / therapeutic use. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Penicillin G / therapeutic use. Risk Factors. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Listeria Infections.
  • Hazardous Substances Data Bank. PENICILLIN G .
  • Hazardous Substances Data Bank. AMPICILLIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16400430.001).
  • [ISSN] 0004-282X
  • [Journal-full-title] Arquivos de neuro-psiquiatria
  • [ISO-abbreviation] Arq Neuropsiquiatr
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 7C782967RD / Ampicillin; Q42T66VG0C / Penicillin G
  •  go-up   go-down


78. Mao P, Luo CR, Zhang YP, Wang CX, Xu YL, Ying Y, DU QH, Xie JJ: [Expression and clonal proliferation of TCR Vbeta subfamilies of peripheral T-cells in acute myeloid leukemia patients]. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr;17(2):431-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression and clonal proliferation of TCR Vbeta subfamilies of peripheral T-cells in acute myeloid leukemia patients].
  • This study was purposed to investigate the expression and clonal proliferation of receptor (TCR) Vbeta subfamilies of the T-cells in acute leukemic patients at different disease status (onset, complete remission or relapse) and to analyze the influence of the leukemic cell load on anti-leukemic effect of peripheral T-lymphocytes of the patients.
  • The application, clonal proliferation, cellular complexity of T-cells, and the variation of immunotypes of T-cells were compared.
  • Only 1 - 2 clonal proliferation of TCR Vbeta subfamilies existed in 9 out of 11 patients at initial diagnosis which increased at remission.
  • There was an obvious decrease of CDR3 complexity at initial diagnosis or relapse, while CDR3 complexity would be partially improved at remission.

  • Genetic Alliance. consumer health - Leukemia, Myeloid.
  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19379582.001).
  • [ISSN] 1009-2137
  • [Journal-full-title] Zhongguo shi yan xue ye xue za zhi
  • [ISO-abbreviation] Zhongguo Shi Yan Xue Ye Xue Za Zhi
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Complementarity Determining Regions; 0 / Receptors, Antigen, T-Cell
  •  go-up   go-down


79. Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ: In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt; 2006 Jul-Aug;11(4):044005
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Our results demonstrate that intrinsic optical signals can be influenced by functional perturbations characteristic of malignant transformation; cellular metabolism, extracellular matrix composition, and angiogenesis.
  • [MeSH-major] Algorithms. Breast Neoplasms / diagnosis. Breast Neoplasms / physiopathology. Diagnosis, Computer-Assisted / methods. Infrared Rays. Spectrophotometry, Infrared / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Middle Aged. Reproducibility of Results. Scattering, Radiation. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16965162.001).
  • [ISSN] 1083-3668
  • [Journal-full-title] Journal of biomedical optics
  • [ISO-abbreviation] J Biomed Opt
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30-CA62203; United States / NCRR NIH HHS / RR / P41-RR01192; United States / NCI NIH HHS / CA / U54-CA105480
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


80. Mentzel T, Kuhnen C: Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases. Virchows Arch; 2006 Nov;449(5):554-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We analysed the clinicopathological and immunohistochemical features of seven new cases of spindle cell RMS arising in adult patients.
  • Histologically, a plump or diffuse infiltration was seen, and all neoplasms were mainly composed of cellular bands and fascicles of atypical spindle-shaped tumour cells containing enlarged and atypical nuclei associated with a variable number of rhabdomyoblasts.
  • Immunohistochemically, tumour cells in RMS stain positively for CD 99 and WT1 as well, which is of importance in the differential diagnosis to other mesenchymal neoplasms, whereas fast myosin does not represent a reliable marker for RMS in adults.
  • [MeSH-minor] Adult. Aged. Antigens, CD / analysis. Antigens, CD99. Cell Adhesion Molecules / analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2003 Aug 1;98(3):571-80 [12879475.001]
  • [Cites] Cancer. 1995 Sep 15;76(6):1073-85 [8625211.001]
  • [Cites] Virchows Arch. 2006 Nov;449(5):572-8 [17016719.001]
  • [Cites] Am J Pathol. 2000 Feb;156(2):399-408 [10666368.001]
  • [Cites] Pediatr Dev Pathol. 2004 Nov-Dec;7(6):583-94 [15630526.001]
  • [Cites] Virchows Arch. 2000 Apr;436(4):305-11 [10834531.001]
  • [Cites] Am J Surg Pathol. 1998 Oct;22(10):1228-38 [9777985.001]
  • [Cites] Am J Surg Pathol. 2002 Sep;26(9):1175-83 [12218574.001]
  • [Cites] Am J Surg Pathol. 1993 Mar;17(3):221-30 [8434703.001]
  • [Cites] Mod Pathol. 2001 Jun;14(6):595-603 [11406662.001]
  • [Cites] Ann Surg. 2001 Aug;234(2):215-23 [11505068.001]
  • [Cites] Cancer. 2001 Feb 15;91(4):794-803 [11241248.001]
  • [Cites] Am J Surg Pathol. 1992 Mar;16(3):229-35 [1599014.001]
  • [Cites] Am J Surg Pathol. 2005 Aug;29(8):1106-13 [16006807.001]
  • [Cites] Mod Pathol. 2002 Oct;15(10):1080-6 [12379755.001]
  • [Cites] Virchows Arch. 2005 Jan;446(1):64-7 [15660283.001]
  • (PMID = 17013628.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD99; 0 / CD99 protein, human; 0 / Cell Adhesion Molecules
  •  go-up   go-down


81. Ho CL, Chen S, Yeung DW, Cheng TK: Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med; 2007 Jun;48(6):902-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have reported previously that (11)C-acetate ((11)C-ACT) PET was complementary to (18)F-FDG PET in the evaluation of primary hepatocellular carcinoma (HCC) in relation to the degree of tumor cellular differentiation.
  • CONCLUSION: This study confirmed that (18)F-FDG PET/CT is useful in the evaluation of HCC metastasis, although its role in the diagnosis of primary HCC is more limited.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Carbon Radioisotopes. Evaluation Studies as Topic. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Positron-Emission Tomography / methods. Retrospective Studies. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. ACETIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17504862.001).
  • [ISSN] 0161-5505
  • [Journal-full-title] Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • [ISO-abbreviation] J. Nucl. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carbon Radioisotopes; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18; Q40Q9N063P / Acetic Acid
  •  go-up   go-down


82. Looijenga LH, Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW: Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis. Ann N Y Acad Sci; 2007 Dec;1120:187-214
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here the focus is on the type II GCTs, the most frequent type in the adult testis (so-called TGCTs).
  • The unusual presence of wild-type P53 in TGCTs is explained by specific expression of a cluster of micro-RNAs (miRNAs), that is, hsa-miR 371-373, also expressed in ES cells, which prevents P53-driven cellular senescence upon oncogenic stress.
  • Demonstration of these characteristics, in combination with the knowledge of the abnormal niche of these cells, normally occupied by spermatogonia, allows an informative method for (early) diagnosis.

  • MedlinePlus Health Information. consumer health - Testicular Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17911410.001).
  • [ISSN] 0077-8923
  • [Journal-full-title] Annals of the New York Academy of Sciences
  • [ISO-abbreviation] Ann. N. Y. Acad. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 206
  •  go-up   go-down


83. McNiff JM, Subtil A, Cowper SE, Lazova R, Glusac EJ: Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans. J Cutan Pathol; 2005 Jul;32(6):413-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans.
  • Cellular variants are not well recognized.
  • We compared the histologic and immunohistochemical features of these cellular fibromas with five digital AFs, five ADFs, and five digital dermatofibromas.
  • RESULTS: The 14 cellular digital fibromas showed intersecting fascicles of thin delicate bland spindle cells in the superficial reticular dermis with a fibrotic-to-slight myxoid stroma.
  • CONCLUSIONS: These findings suggest that a subset of digital fibromas is characterized by a dense cellular proliferation of CD34-positive spindle cells.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antigens, CD34 / metabolism. Biomarkers, Tumor / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Middle Aged


84. Palmer S, Hanson CA, Zent CS, Porrata LF, Laplant B, Geyer SM, Markovic SN, Call TG, Bowen DA, Jelinek DF, Kay NE, Shanafelt TD: Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia. Br J Haematol; 2008 May;141(5):607-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.
  • Patients with chronic lymphocytic leukaemia (CLL) have a variable clinical course.
  • The absolute number of T-cell and natural killer (NK)-cells was calculated for 166 consecutive patients with CLL evaluated by flow cytometry at Mayo Clinic < or = 2 months of diagnosis.
  • Patients exhibited substantial variation in the absolute number of T- and NK-cells as well as T:MBC and NK:MBC ratios at diagnosis.
  • These characteristics can be modified and continued evaluation of immunomodulatory drugs, vaccination strategies and cellular therapies to delay/prevent disease progression are warranted.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 1999 Dec 1;94(11):3889-96 [10572105.001]
  • [Cites] Leukemia. 1997 Jun;11(6):775-8 [9177426.001]
  • [Cites] Haematologica. 2001 Jan;86(1):8-12 [11146563.001]
  • [Cites] Br J Haematol. 2001 Dec;115(4):854-61 [11843819.001]
  • [Cites] Br J Haematol. 2003 Apr;121(2):287-95 [12694251.001]
  • [Cites] Blood. 2003 Aug 1;102(3):1057-63 [12689926.001]
  • [Cites] Blood. 2004 Feb 15;103(4):1202-10 [14576043.001]
  • [Cites] Blood. 2004 Sep 1;104(5):1258-65 [15126323.001]
  • [Cites] N Engl J Med. 2004 Aug 26;351(9):893-901 [15329427.001]
  • [Cites] Mayo Clin Proc. 1994 Apr;69(4):323-8 [8170175.001]
  • [Cites] Blood. 1996 Jun 15;87(12):4990-7 [8652811.001]
  • [Cites] Blood. 2005 Oct 1;106(7):2506-12 [15972449.001]
  • [Cites] Clin Lymphoma Myeloma. 2006 Mar;6(5):393-8 [16640816.001]
  • [Cites] J Clin Oncol. 2006 Jul 1;24(19):3218-9; author reply 3219-20 [16809747.001]
  • [Cites] Br J Haematol. 2006 Sep;134(6):596-601 [16889618.001]
  • [Cites] J Clin Oncol. 2006 Oct 1;24(28):4634-41 [17008705.001]
  • [Cites] Br J Haematol. 2007 Jun;137(5):409-15 [17433025.001]
  • [Cites] Leukemia. 2007 Sep;21(9):1885-91 [17568813.001]
  • [Cites] Leukemia. 2007 Dec;21(12):2554-6 [17581607.001]
  • [Cites] Haematologica. 1999 Dec;84(12):1094-9 [10586211.001]
  • (PMID = 18384436.001).
  • [ISSN] 1365-2141
  • [Journal-full-title] British journal of haematology
  • [ISO-abbreviation] Br. J. Haematol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA97274; United States / NCI NIH HHS / CA / CA113408; United States / NCI NIH HHS / CA / K07 CA094919; United States / NCI NIH HHS / CA / CA94919; United States / NCI NIH HHS / CA / P50 CA097274; United States / NCI NIH HHS / CA / K23 CA113408
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Membrane Glycoproteins; EC 3.2.2.5 / Antigens, CD38; EC 3.2.2.5 / CD38 protein, human
  • [Other-IDs] NLM/ NIHMS458045; NLM/ PMC3840945
  •  go-up   go-down


85. Plaza JA, Torres-Cabala C, Evans H, Diwan AH, Prieto VG: Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases. Am J Dermatopathol; 2009 Jul;31(5):419-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases.
  • Neurothekeoma is a term introduced by Gallager and Helwig describing a superficial tumor of purported nerve sheath derivation, with cellular and myxoid types.
  • Recently, it has been suggested that the cellular type does not have nerve sheath differentiation.
  • We studied the immunohistochemical features of 31 cases of cellular neurothekeomas to evaluate their immunoprofile.
  • Therefore, the combination of strong immunoreactivity for S100A6, in nested dermal spindle cell proliferations, and lack of S100 protein or keratin, supports a diagnosis of cellular neurothekeoma.
  • [MeSH-minor] Adolescent. Adult. Child. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Immunophenotyping. Male. Melanoma / pathology. Middle Aged. Young Adult

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19542912.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cell Cycle Proteins; 0 / S100 Proteins; 105504-00-5 / S100A6 protein, human
  •  go-up   go-down


86. Inogès S, Rodrìguez-Calvillo M, Zabalegui N, Lòpez-Dìaz de Cerio A, Villanueva H, Soria E, Suárez L, Rodríguez-Caballero A, Pastor F, García-Muñóz R, Panizo C, Pèrez-Calvo J, Melero I, Rocha E, Orfao A, Bendandi M, Grupo Español de Linfomas/Trasplante Autologo de Medula Oseo study group, Programa para el Estudio y Tratamiento de Hemopatias Malignas study group: Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma. J Natl Cancer Inst; 2006 Sep 20;98(18):1292-301
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Specific humoral and cellular responses were assessed, and patients were followed for disease recurrence.
  • In 20 patients (80%), a humoral (13/20) and/or a cellular (18/20) idiotype-specific response was detected.
  • [MeSH-minor] Adult. Aged. Disease-Free Survival. Female. Humans. Male. Matched-Pair Analysis. Middle Aged. Neoplasm Staging. Neoplasm, Residual / diagnosis. Neoplasm, Residual / metabolism. Polymerase Chain Reaction. Polymorphism, Genetic. Proto-Oncogene Proteins c-bcl-2 / metabolism. Receptors, Fc / genetics. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Follicular Lymphoma.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Natl Cancer Inst. 2006 Sep 20;98(18):1263-5 [16985240.001]
  • (PMID = 16985248.001).
  • [ISSN] 1460-2105
  • [Journal-full-title] Journal of the National Cancer Institute
  • [ISO-abbreviation] J. Natl. Cancer Inst.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cancer Vaccines; 0 / Immunoglobulin Idiotypes; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Receptors, Fc
  •  go-up   go-down


87. Ramos-Herberth FI, Karamchandani J, Kim J, Dadras SS: SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar. J Cutan Pathol; 2010 Sep;37(9):944-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Sry-related HMG-BOX gene 10 (SOX10), a nuclear transcription factor that plays an important role in schwannian and melanocytic cell differentiation, has recently been shown to be a useful marker in the diagnosis of melanocytic and schwannian tumors.
  • The staining intensity for all the cellular components in melanoma and scar specimens was scored.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Cicatrix / diagnosis. Melanoma / diagnosis. Precancerous Conditions / diagnosis. SOXE Transcription Factors / metabolism. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Child, Preschool. Diagnosis, Differential. Female. Humans. Male. Middle Aged


88. Mendoza Sánchez A, Sobrino Cossio S, Hernández Guerrero A, Córdova Pluma VH, Alonso Lárraga O, Sánchez del Monte Dr: [Utility of diagnostic scales for hereditary non-polyposis colon cancer in the Mexican population]. Rev Gastroenterol Mex; 2005 Oct-Dec;70(4):411-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Diagnosis is made by means of the Amstedam criteria, or the modified Amsterdam and Bethesda.
  • OBJECTIVE: Aim was to evaluate the clinical application of the diagnostic scales for HNPCC in our population and to determine the clinical characteristics that these patients reveal at the time of diagnosis.
  • The demographic data, patients and relatives history and the characteristics of the tumor were obtained at the time of diagnosis.
  • In 53.6% the tumor was located in right colon, regardless histology they had mucin component and poor cellular differentiation.
  • [MeSH-major] Colorectal Neoplasms, Hereditary Nonpolyposis / diagnosis
  • [MeSH-minor] Adult. Cross-Sectional Studies. Female. Humans. Male. Mexico. Middle Aged. Retrospective Studies

  • Genetic Alliance. consumer health - Hereditary Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17058980.001).
  • [ISSN] 0375-0906
  • [Journal-full-title] Revista de gastroenterología de México
  • [ISO-abbreviation] Rev Gastroenterol Mex
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


89. French CA: NUT midline carcinoma. Cancer Genet Cytogenet; 2010 Nov;203(1):16-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Diagnosis of NMC is made by demonstration of expression of the NUT-fusion protein using a monoclonal antibody to NUT for immunohistochemistry, and confirmation of the fusion (BRD-NUT or NUT-variant) by fluorescent in situ hybridization or reverse transcriptase-polymerase chain reaction.
  • BRD-NUT functions to block cellular differentiation and promote uncontrolled growth of carcinoma cells.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Humans. Male. Middle Aged. Oncogene Proteins, Fusion / genetics. Transcription Factors / genetics

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • [Cites] Mol Cell Biol. 2000 Sep;20(17):6537-49 [10938129.001]
  • [Cites] Head Neck Pathol. 2010 Jun;4(2):163-8 [20352379.001]
  • [Cites] Cancer. 2001 Sep 1;92(5):1195-203 [11571733.001]
  • [Cites] Am J Pathol. 2001 Dec;159(6):1987-92 [11733348.001]
  • [Cites] Cancer Res. 2003 Jan 15;63(2):304-7 [12543779.001]
  • [Cites] Am J Clin Oncol. 2003 Jun;26(3):300-6 [12796605.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8758-63 [12840145.001]
  • [Cites] J Clin Oncol. 2004 Oct 15;22(20):4135-9 [15483023.001]
  • [Cites] Cancer Res. 1991 Jun 15;51(12):3327-8 [2040007.001]
  • [Cites] Int J Cancer. 1992 Jan 21;50(2):259-64 [1730520.001]
  • [Cites] Am J Pediatr Hematol Oncol. 1991 Winter;13(4):459-64 [1785673.001]
  • [Cites] Cancer. 1993 Oct 1;72(7):2273-6 [8374886.001]
  • [Cites] Mol Cell. 2005 Aug 19;19(4):523-34 [16109376.001]
  • [Cites] Mol Cell. 2005 Aug 19;19(4):535-45 [16109377.001]
  • [Cites] BMC Cancer. 2006;6:69 [16542442.001]
  • [Cites] Pediatr Blood Cancer. 2007 Dec;49(7):1015-7 [16435379.001]
  • [Cites] Mol Cell Biol. 2008 Feb;28(3):967-76 [18039861.001]
  • [Cites] J Biol Chem. 2008 Apr 4;283(14):9040-8 [18223296.001]
  • [Cites] Oncogene. 2008 Apr 3;27(15):2237-42 [17934517.001]
  • [Cites] Am J Surg Pathol. 2008 Jun;32(6):828-34 [18391746.001]
  • [Cites] Am J Surg Pathol. 2009 Aug;33(8):1253-8 [19561446.001]
  • [Cites] Am J Surg Pathol. 2009 Jul;33(7):984-91 [19363441.001]
  • [Cites] J Clin Pathol. 2010 Jun;63(6):492-6 [18552174.001]
  • [Cites] J Natl Cancer Inst. 2000 Aug 16;92(16):1355-7 [10944559.001]
  • (PMID = 20951314.001).
  • [ISSN] 1873-4456
  • [Journal-full-title] Cancer genetics and cytogenetics
  • [ISO-abbreviation] Cancer Genet. Cytogenet.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / K08 CA092158; United States / NCI NIH HHS / CA / L40 CA108477; United States / NCI NIH HHS / CA / R01 CA124633
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BRD4 protein, human; 0 / BRD4-NUT fusion oncogene protein, human; 0 / NUT protein, human; 0 / Nuclear Proteins; 0 / Oncogene Proteins; 0 / Oncogene Proteins, Fusion; 0 / Transcription Factors
  • [Other-IDs] NLM/ NIHMS240477; NLM/ PMC3000636
  •  go-up   go-down


90. Passamonti B, Bulletti S, Camilli M, D'Amico MR, Di Dato E, Gustinucci D, Martinelli N, Malaspina M, Spita N: Evaluation of the FocalPoint GS system performance in an Italian population-based screening of cervical abnormalities. Acta Cytol; 2007 Nov-Dec;51(6):865-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the 418 cellular abnormalities found, 409 were classified for Review by FPGS and 9 minor grade lesions were classified in the "No Further Review" population.
  • Location-guided software identified cellular abnormalities, in the automatically selected fields of view, in 378 (92%) of the ranked abnormal slides, showing a sensitivity > 95% on SILs.
  • [MeSH-major] Diagnosis, Computer-Assisted. Mass Screening / methods. Papanicolaou Test. Uterine Cervical Diseases / diagnosis. Uterine Cervical Diseases / prevention & control. Vaginal Smears / methods
  • [MeSH-minor] Adult. Cervical Intraepithelial Neoplasia / diagnosis. Female. Humans. Italy. Middle Aged. Prospective Studies. Uterine Cervical Neoplasms / diagnosis. Uterine Cervical Neoplasms / prevention & control

  • MedlinePlus Health Information. consumer health - Cervical Cancer Screening.
  • MedlinePlus Health Information. consumer health - Cervix Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18077978.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Wang SL, Wu MT, Yang SF, Chan HM, Chai CY: Computerized nuclear morphometry in thyroid follicular neoplasms. Pathol Int; 2005 Nov;55(11):703-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Differential diagnosis of follicular adenoma (FA) and follicular carcinoma (FC) of the thyroid can be challenging in the routine practice of surgical pathology because the diagnosis of FC is strictly defined and identification depends on the presence of invasion of the capsule or blood vessels.
  • Computerized morphometry is a scientific tool to evaluate cellular changes and it can enhance the interpretation of morphological features by the transformation of pathological changes in cells to a qualitative form.
  • In conclusion, computerized nuclear morphometry can be considered a helpful ancillary tool for differential diagnosis of FA and FC.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Image Processing, Computer-Assisted. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16271082.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  •  go-up   go-down


92. Lombardi F, Calosso E, Mascioli G, Marangoni E, Donato A, Rossi S, Pala M, Foti F, Lunati M: Utility of implantable loop recorder (Reveal Plus) in the diagnosis of unexplained syncope. Europace; 2005 Jan;7(1):19-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Utility of implantable loop recorder (Reveal Plus) in the diagnosis of unexplained syncope.
  • Thus, when considering all 18 patients with recurrences, a diagnosis was achieved in 53% of subjects.
  • [MeSH-major] Electrocardiography, Ambulatory / instrumentation. Syncope / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chi-Square Distribution. Female. Humans. Male. Middle Aged. Prospective Studies

  • MedlinePlus Health Information. consumer health - Fainting.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15670962.001).
  • [ISSN] 1099-5129
  • [Journal-full-title] Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • [ISO-abbreviation] Europace
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  •  go-up   go-down


93. Lee CC, Ho HC, Lee MS, Hung SK, Yu CC, Su YC: Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma. Clin Chim Acta; 2010 Aug 5;411(15-16):1116-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We study patients with HNSCC without distant metastasis at diagnosis.
  • Correlation between cellular haptoglobin and clinical characteristics of HNSCC was analyzed to assess the prognostic value of cellular haptoglobin level.
  • Kaplan-Meier survival curves and log-rank test were used to evaluate differences in recurrence, distant metastasis, and overall survival rates between patients grouped according to cellular haptoglobin level in cancer tissues.
  • CONCLUSIONS: Altogether, the data presented show that cellular expression of haptoglobin is closely related to recurrence rate in HNSCC patients.
  • The cellular expression of haptoglobin may be a prognostic factor in HNSCC.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / genetics. Gene Expression Regulation, Neoplastic. Haptoglobins / metabolism. Head and Neck Neoplasms / diagnosis. Head and Neck Neoplasms / genetics
  • [MeSH-minor] Adult. Aged. Cell Line, Tumor. Disease-Free Survival. Female. Humans. Male. Middle Aged. Recurrence

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier B.V. All rights reserved.
  • (PMID = 20417195.001).
  • [ISSN] 1873-3492
  • [Journal-full-title] Clinica chimica acta; international journal of clinical chemistry
  • [ISO-abbreviation] Clin. Chim. Acta
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Haptoglobins
  •  go-up   go-down


94. Willems SM, Mohseny AB, Balog C, Sewrajsing R, Briaire-de Bruijn IH, Knijnenburg J, Cleton-Jansen AM, Sciot R, Fletcher CD, Deelder AM, Szuhai K, Hensbergen PJ, Hogendoorn PC: Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix. J Cell Mol Med; 2009 Jul;13(7):1291-301
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.
  • Cellular myxoma and grade I myxofibrosarcoma are mesenchymal tumours that are characterized by their abundant myxoid extracellular matrix (ECM).
  • Diagnosis is therefore difficult though important.
  • A well-documented series of intramuscular myxoma (three typical cases and seven cases of the more challenging cellular variant) and grade I myxofibrosarcoma (n = 10) cases were karyotyped, analyzed for GNAS1, KRAS and TP53 mutations and downstream activation of c-Fos mRNA and protein expression.
  • Intramuscular/cellular myxoma and grade I myxofibrosarcoma show different molecular genetic aberrations and different composition of their ECM that probably contribute to their diverse clinical behaviour.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chromatography, Liquid. DNA Mutational Analysis. Extracellular Matrix Proteins / metabolism. Female. GTP-Binding Protein alpha Subunits, Gs / genetics. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. Karyotyping. Male. Mass Spectrometry. Middle Aged. Polymerase Chain Reaction. Proto-Oncogene Proteins / genetics. RNA, Messenger / genetics. RNA, Messenger / metabolism. Tumor Suppressor Protein p53 / genetics. ras Proteins / genetics

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19320777.001).
  • [ISSN] 1582-4934
  • [Journal-full-title] Journal of cellular and molecular medicine
  • [ISO-abbreviation] J. Cell. Mol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Extracellular Matrix Proteins; 0 / KRAS protein, human; 0 / Proto-Oncogene Proteins; 0 / RNA, Messenger; 0 / Tumor Suppressor Protein p53; EC 3.6.1.- / GNAS protein, human; EC 3.6.5.1 / GTP-Binding Protein alpha Subunits, Gs; EC 3.6.5.2 / ras Proteins
  • [Other-IDs] NLM/ PMC4496143
  •  go-up   go-down


95. Moran CA, Suster S, Silva EG: Low-grade serous carcinoma of the ovary metastatic to the anterior mediastinum simulating multilocular thymic cysts: a clinicopathologic and immunohistochemical study of 3 cases. Am J Surg Pathol; 2005 Apr;29(4):496-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, within the cystic structures, there was a neoplastic cellular proliferation with papillary architecture, nuclear atypia, and scattered mitotic figures.
  • Two patients remain alive and well after follow-up ranging from 6 to 18 months and 1 patient died of tumor 18 years after initial diagnosis.
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Keratins / analysis. Middle Aged

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15767804.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 68238-35-7 / Keratins
  •  go-up   go-down


96. Cong WM, Zhang SY, Wang ZL, Xue L, Liu YS, Zhang SH: [Pathologic diagnosis of 1123 post-transplant liver biopsies from 665 liver transplant patients]. Zhonghua Bing Li Xue Za Zhi; 2005 Nov;34(11):716-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pathologic diagnosis of 1123 post-transplant liver biopsies from 665 liver transplant patients].
  • OBJECTIVE: To summarize the Chinese experience in pathologic diagnosis of liver biopsies after orthotopic liver transplantation (OLTx).
  • The 5 most common complications were acute cellular rejection (35.6%), ischemic-reperfusion injury (13.4%), biliary stricture (5.6%), drug complication (5.0%) and chronic rejection (4.7%).
  • The 5 earliest complications after OLTx were primary non-function (occurring at day 4.7 +/- 2.1), ischemic-reperfusion injury (occurring at day 14.0 +/- 4.0), acute cellular rejection (occurring at day 32.1 +/- 62.9), hepatic artery thrombosis / stricture (occurring at day 62.9 +/- 74.2) and cytomegalovirus infection (occurring at day 107.7 +/- 93.0).
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biopsy, Needle. Child. Child, Preschool. Cholestasis, Intrahepatic / pathology. Female. Hepatic Artery / pathology. Humans. Infant. Male. Middle Aged. Reperfusion Injury / pathology. Retrospective Studies. Thrombosis / pathology

  • Genetic Alliance. consumer health - Liver Transplant.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Liver Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16536315.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Multicenter Study
  • [Publication-country] China
  •  go-up   go-down


97. Watanabe K, Suzuki T: Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics. Histopathology; 2006 Apr;48(5):563-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics.
  • [MeSH-minor] Actins / analysis. Adult. Calmodulin-Binding Proteins / analysis. Desmin / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Middle Aged. Muscle, Smooth / chemistry. Prognosis. Receptors, Estrogen / analysis. Receptors, Progesterone / analysis


98. Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA: ST-segment depression as a risk factor in hypertrophic cardiomyopathy. Europace; 2009 May;11(5):643-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS AND RESULTS: We retrospectively analysed data on 173 consecutive patients admitted to our centre with a diagnosis of HCM.
  • [MeSH-major] Cardiomyopathy, Hypertrophic / diagnosis. Cardiomyopathy, Hypertrophic / physiopathology. Death, Sudden, Cardiac / epidemiology. Electrocardiography
  • [MeSH-minor] Adolescent. Adult. Aged. Algorithms. Child. Defibrillators, Implantable. Electrocardiography, Ambulatory. Female. Humans. Male. Middle Aged. Multivariate Analysis. Predictive Value of Tests. Prognosis. Retrospective Studies. Risk Factors. Young Adult


99. Jakobiec FA, Bhat P, Colby KA: Immunohistochemical studies of conjunctival nevi and melanomas. Arch Ophthalmol; 2010 Feb;128(2):174-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To evaluate the role of immunohistochemical methods in the diagnosis of benign and malignant conjunctival melanocytic proliferations.
  • METHODS: Paraffin-embedded tissue sections from 20 conjunctival nevi and 15 invasive melanomas were immunoreacted with antibodies against cellular antigens S-100 protein, MART-1, HMB-45, CD-45, and Ki-67 nuclear proliferation protein.
  • [MeSH-major] Biomarkers, Tumor / analysis. Conjunctival Neoplasms / diagnosis. Melanoma / diagnosis. Neoplasm Proteins / analysis. Nevus, Pigmented / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Antigens, CD45 / analysis. Antigens, Neoplasm / analysis. Child. Diagnosis, Differential. Female. Humans. Immunoenzyme Techniques. Ki-67 Antigen / analysis. MART-1 Antigen. Male. Melanoma-Specific Antigens. Middle Aged. Retrospective Studies. S100 Proteins / analysis. Young Adult

  • MedlinePlus Health Information. consumer health - Melanoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20142539.001).
  • [ISSN] 1538-3601
  • [Journal-full-title] Archives of ophthalmology (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / MART-1 Antigen; 0 / MLANA protein, human; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins; 0 / S100 Proteins; EC 3.1.3.48 / Antigens, CD45; EC 3.1.3.48 / PTPRC protein, human
  •  go-up   go-down


100. Adeolu AA, Shokunbi MT, Malomo AO, Akang EA, Obajimi MO, Komolafe EO: Solitary intracranial tuberculoma in patients without immuno-suppression: a report of three cases. Niger Postgrad Med J; 2006 Mar;13(1):69-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cranial computed tomography scans demonstrated uniformly contrast enhancing falcine supratentorial masses in the adult patients and a cerebellar hemispheric lesion with peripheral contrast enhancement in the paediatric patient INTERVENTION: All the patients had gross total tumour excision.
  • CONCLUSION: Intracranial tuberculoma can occur in otherwise healthy individuals and should always be considered in the differential diagnosis of solitary intracranial mass lesions in sub-Saharan Africans so that minimally invasive procedures can be used to establish the correct diagnosis.
  • [MeSH-major] Cerebellum. Immunity, Cellular. Tuberculoma, Intracranial / radiography
  • [MeSH-minor] Antitubercular Agents / therapeutic use. Child. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Prognosis. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16633384.001).
  • [ISSN] 1117-1936
  • [Journal-full-title] The Nigerian postgraduate medical journal
  • [ISO-abbreviation] Niger Postgrad Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Nigeria
  • [Chemical-registry-number] 0 / Antitubercular Agents
  •  go-up   go-down






Advertisement